Introduction {#s1}
============

GABAergic cortical inhibitory interneurons (cINs) regulate neuronal circuits in the neocortex. The ratio of inhibitory interneurons to excitatory neurons is crucial for establishing and maintaining proper brain function ([@bib58]; [@bib9]; [@bib44]; [@bib25]; [@bib30]; [@bib59]). Alterations in the number of cINs have been linked to epilepsy ([@bib14]), schizophrenia ([@bib4]; [@bib24]; [@bib15]) and autism ([@bib20]; [@bib8]; [@bib17]). During mouse embryonic development, the brain produces an excess number of cINs and \~40% of those are subsequently eliminated by apoptosis during early postnatal life, between postnatal day (P)1 and 15 ([@bib64]; [@bib12]; [@bib71]). What makes the death of these cells intriguing is its timing and location. In normal development, cINs are generated in the medial and caudal ganglionic eminences (MGE; CGE) of the ventral forebrain, far from their final target destination in the cortex. cINs migrate tangentially from their site of origin to reach the neocortex, where they become synaptically integrated and complete their maturation ([@bib2]; [@bib70]; [@bib5]; [@bib49]). The ganglionic eminences are also an important source of interneurons in the developing human brain, where migration and differentiation extend into postnatal life ([@bib22]; [@bib52]; [@bib43]). How is the final number of cINs regulated once these cells arrive in the cortex?

Since cINs play a pivotal role in regulating the level of cortical inhibition, the adjustment of their number by programmed cell death is a key feature of their development and essential for proper brain physiology. While recent work suggests that activity-dependent mechanisms regulate cIN survival through their connectivity to excitatory neurons ([@bib71]; [@bib12]; [@bib13]; [@bib54]) studies indicate that cIN survival is mediated by a population-autonomous (or cell-autonomous) mechanism ([@bib64]). Heterochronically transplanted MGE cIN precursors undergo a wave of apoptosis coinciding with their age, which is asynchronous from endogenous cINs. Whereas it is well established that neuronal survival in the peripheral nervous system (PNS) is regulated through limited access to neurotrophic factors secreted by target cells ([@bib31]; [@bib1]; [@bib51]), cIN survival is independent of TrkB, the main neurotrophin receptor expressed by neurons of the CNS ([@bib64]; [@bib56]). Moreover, the proportion of cINs undergoing apoptosis remains constant across graft sizes that vary 200-fold ([@bib64]). Taken together, this work suggests that cIN developmental death is intrinsically determined and that cell-autonomous mechanisms within the maturing cIN population contribute to the regulation of their survival.

The clustered protocadherins (Pcdh) ([@bib73]) are a set of cell surface homophilic-binding proteins implicated in neuronal survival and self-avoidance in the spinal cord, retina, cerebellum, hippocampus, and olfactory bulb glomeruli ([@bib32]; [@bib69]; [@bib41], [@bib40]; [@bib35]; [@bib47]; [@bib11]). In the mouse, the Pcdh locus encodes a total of 58 isoforms that are arranged in three gene clusters, alpha, beta and gamma: *Pcdha*, *Pcdhb*, and *Pcdhg* ([@bib72]). The *Pcdha* and *Pcdhg* isoforms are each composed of a set of variable exons, which are spliced to three common constant cluster-specific exons ([@bib67]; [@bib68]). Each variable exon codes for the extracellular, transmembrane and most-proximal intracellular domain of a protocadherin protein. The *Pcdhb* isoforms are encoded by single exon genes encoding both extracellular, transmembrane and cytoplasmic domains ([@bib73]). Of the 58 *Pcdh* genes, it has been suggested that a combinatorial, yet stochastic, set of isoforms is expressed in each neuron ([@bib16]; [@bib33]; [@bib47]), suggesting a source for neuronal diversity in the CNS ([@bib6]). Interestingly, *Pcdhg* genes, and specifically isoforms *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5*, are required for the postnatal survival of mice ([@bib69]; [@bib23]; [@bib10]). Whether Pcdh genes are required for the regulation of cIN elimination remains unknown.

In the present study, we used a series of genetic deletions of the Pcdh gene locus to probe the role of clustered Pcdhs in the regulation of cIN cell death in mice. We show that *Pcdhg*, but not *Pcdha* or *Pcdhb*, are required for the survival of approximately 50% of cINs through a BAX-dependent mechanism. Using co-transplantation of *Pcdhg*-deficient and wild-type (WT) cINs of the same age, we show that they compete for survival in a mechanism that involves *Pcdhg*. Taking advantage of the transplantation assay, we show that removal of the three *Pcdhg* isoforms, *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5*, is sufficient to increase cell death of MGE-derived cINs. Three-dimensional reconstructions and patch-clamp recordings indicate that the *Pcdhg* mutant cells have similar morphology, excitability and receive similar numbers of inhibitory and excitatory synaptic inputs compared to wild type cINs. We conclude that cIN cell death is regulated by all or some of the C-isoforms in the *Pcdhg* cluster and that this process is independent of the structural complexity or intrinsic physiological properties of the cell or the strength of its excitatory and inhibitory synaptic inputs.

Results {#s2}
=======

*Pcdhg* expression in developing cINs {#s2-1}
-------------------------------------

Expression of clustered protocadherins (Pcdh) in the brain starts in the embryo and continues postnatally ([@bib27]; [@bib19]; [@bib69]; [@bib36]). RT-PCR analysis revealed the expression of each of the 58 isoforms in the Pcdh gene locus in the adult cortex (P30) ([Figure 1A](#fig1){ref-type="fig"}). Of the 58 Pcdh genes, those in the *Pcdhg* cluster are essential for postnatal survival ([@bib23]; [@bib10]), and are implicated in cell death in the retina and spinal cord ([@bib40]; [@bib53]). We, therefore, determined whether *Pcdhg* genes are expressed in cINs during the period of cIN cell death. Using *Gad1*-GFP mice to label GABAergic cINs ([@bib65]), we FACS-sorted GFP-positive (GFP+) and GFP-negative (GFP-) cells from P7 mice at the peak of cIN cell death ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). We confirmed that GABAergic cell markers (*Gad1*, *Gad2*) were enriched in the GFP+ population, while markers of excitatory neurons (*Tbr1, Satb2, Otx1*), astrocytes (*Gfap*, *Aldh1l1*), and oligodendrocytes (*Olig2*, *Mbp*) were enriched in the GFP- population ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). With the exception of *Pcdhg*a*9* isoform, we detected the expression of all other 21 *Pcdhg* in cINs ([Figure 1B](#fig1){ref-type="fig"}). To determine the expression pattern of *Pcdhg* at different stages during the period of cell death, we measured the expression level of 8 *Pcdhg* mRNAs (*Pcdhgc3*, *Pcdhgc4*, *Pcdhgc5*, *Pcdhga1*, *Pcdhga2*, *Pcdhga3*, *Pcdhgb6*, and *Pcdhgb*7) at P2, P5, P8, P12 and P15 using qPCR ([Figure 1C](#fig1){ref-type="fig"}). All eight isoforms were expressed in cINs at each of the five ages studied. Interestingly, the expression of *Pcdhgc5* increased dramatically between P8 and P15. An increase in expression of *Pcdhg* isoforms *Pcdhga1*, *Pcdhga2* and *PcdhgC4* was also observed at P12, compared to other ages, but this increase was less pronounced than that observed for *Pcdhgc5*. The above results show that all Pcdh isoforms are expressed in cINs and that the expression of *Pcdhg* isoforms *Pcdhga1*, *Pcdhga2* and *PcdhgC4* and *Pcdhgc5* increases during the period of postnatal cell death.

![Expression of clustered Pcdhs in the mouse cortex and purified cortical GABAergic cells.\
( **A**) PCR analysis of clustered *Pcdh* and *Gapdh* gene expression in P30 whole cortex extracts. (**B**) PCR analysis of *Pcdhg* and *Gapdh* gene expression in purified P7 cortical GABAergic cells. (**C**) Quantification of target gene mRNA levels at various postnatal stages (P2, P5, P8, P12, P15) in purified cortical GABAergic cells. P2 mRNA levels used as a reference for each gene (Kruskal-Wallis test, P value = 0.0007 \[ *Pcdhgc4*\], P value \< 0.0001 \[*Pcdhgc5*\], P value = 0.015 \[*Pcdhga1*\], P value = 0.024\[*Pcdhga2*\], P value = 0.003\[*Pcdhg*a3\], P value = 0.038\[*Pcdhgb*6\]; n = 3 technical replicas\]. Significant p values are marked with\*. See [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} for followup of comparisons.\
Figure 1---source data 1.*Pcdhg* expression in cortex.](elife-55374-fig1){#fig1}

Reduced number of cINs in the cortex of *Pcdhg* mutants {#s2-2}
-------------------------------------------------------

Most cINs are produced between embryonic days (E) 10.5 and 16.5 by progenitors located in the medial and caudal ganglionic eminences (MGE and CGE) ([@bib2]; [@bib70]; [@bib48]; [@bib46]). To address the potential role of *Pcdhg* in cIN development, we used the *Pcdhg* conditional allele (*Pcdhg^fcon3^*) to block production of all 22 *Pcdhg* isoforms ([@bib40]). In the *Pcdhg^fcon3^* allele, the third common exon shared by all *Pcdhg* isoforms contains the sequence coding for GFP and is flanked by loxP sites ([@bib40]; [Figure 2A](#fig2){ref-type="fig"}). In unrecombined *Pcdhg^fcon3^* mice, all *Pcdhg* isoforms are thus fused to GFP. However, when these animals are crossed to a Cre driver line, expression of the entire *Pcdhg* cluster is abolished in Cre-expressing cells ([@bib53]). Robust GFP expression was detected throughout the brain in E13.5 embryos, including cells in the MGE and CGE ([Figure 3B](#fig3){ref-type="fig"}), indicating expression of *Pcdhg* isoforms in cIN progenitors. We crossed *Pcdhg^fcon3^* mice to *Gad2^Cre^* mice ([@bib66]) to conditionally ablate all *Pcdhg* in GABAergic cells throughout the CNS at an early embryonic stage (E10.5) ([@bib34]). Recombined cells were visualized thanks to the conditional Ai14 (tdTomato) reporter expression ([Figure 2A](#fig2){ref-type="fig"}). Heterozygous *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/^*^+^ mice were viable and fertile. However, homozygous *Gad2^Cre^;*Ai14 *;Pcdhg^fcon3/fcon3^* mice displayed growth retardation after birth, a hind limb paw-clasping phenotype when held by the tail and were infertile ([Figure 2B](#fig2){ref-type="fig"}). Brain size as well as cerebral cortex thickness of homozygous *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* was similar to those of control mice ([Figure 2B'](#fig2){ref-type="fig"}). However, the density of tdTomato positive cells in somatosensory and visual cortex was roughly halved in homozygous *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* animals, compared to wild type and heterozygous littermates ([Figure 2C and C'](#fig2){ref-type="fig"}). The density of cINs stained positive for parvalbumin (PV) and somatostatin (SST) (MGE-derived), vasoactive intestinal peptide (VIP )(CGE-derived) or reelin (RLN) (derived from both the MGE and CGE) was significantly reduced in the visual cortex of homozygous *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice ([Figure 2D](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Taken together, these experiments indicate that the embryonic loss of *Pcdhg* function in GABAergic progenitor cells leads to a drastically reduced number of cINs in the neocortex, affecting all cIN subtypes similarly.

![Reduced number of GABAergic cINs in *Pcdhg*-deficient mice.\
(**A**) Mutant mice with loss of *Pcdhg* in GABAergic neurons were generated by crossing conditional *Pcdhg^fcon3^* mice to Pan-GABAergic Cre driver (*Gad2*) mice. The conditional Ai14 reporter was used to fluorescently label *Gad2*-expressing cells. (**B**) Photographs of P21 *Gad2^Cre^;*Ai14 mice that are wild type (WT) or mutant (*Pcdhg^fcon3/fcon3^*) for *Pcdhg.* (**B'**) Body weight and cortical thickness measurements in P30 *Gad2^Cre^;*Ai14*;Pcdhg^+/+^* (*Pcdhg* WT), *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/+^* (*Pcdhg* HET), and *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) mice(Kruskal-Wallis test, P value=0.0027, adjusted p values \*\*p=0.0017, n = 12 mice \[*Pcdhg* WT\], n = 7 mice \[*Pcdhg* HET\] and n = 5 mice \[*Pcdhg* mutant\]). (**C**) Photographs of coronal sections in primary visual cortex (V1) of P30 *Gad2*^Cre^;Ai14*; Pcdhg* WT (left), *Pcdhg* HET (middle) and *Pcdhg* mutant (right) mice. All cortical layers are similarly affected ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Scale bar, 100 μm. (**C'**) Quantifications of tdTomato+ cell density in V1 and somatosensory (S1BF) cortex of P30 *Gad2^Cre^;*Ai14 *Pcdhg* WT(black), *Pcdhg* HET (grey), and *Pcdhg* mutant (magenta) mice (Kruskal-Wallis test; for V1 (P value = 0.006), for S1BF (P value = 0.009); adjusted p values \*\*p=0.0180, \*p=0.036, n = 3--5 mice of each genotype). (**D**) Quantifications of cIN subtype density in V1 cortex at P30. All four non-overlapping cIN subtypes (PV, SST, RLN, and VIP) were similarly reduced in numbers in *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice (*Pcdhg* mutant, magenta) compared to WT controls (Kruskal-Wallis test; for PV (P value = 0.0002), for SST (P value=0.0021), for RLN (P value = 0.0012), and for VIP (P value=0.0093); adjusted p values \*\*p=0.004 (PV), \*\*p=0.0073(SST), \*\*p=0.0093(RLN), \*p=0.0365 (VIP), n = 3--5 mice of each genotype).\
Figure 2---source data 1.Quantification of GABAergic cINs, body weight and cortical thickness measurements in controls and *Pcdhg* deficient mice.](elife-55374-fig2){#fig2}

![Loss of *Pcdhg* genes targeted to Nkx2.1 expressing cells results in selective loss of cIN derived from the MGE.\
( **A**) Mutant mice with loss of *Pcdhg* in MGE-derived cIN were generated by crossing *Pcdhg^fcon3^* mice to Nkx2.1*^Cre^* mice. The conditional Ai14 line was used to fluorescently label MGE-derived cells. (**B**) *Pcdhg^fcon3/fcon3^* mice (at E13.5; top panels) carrying the *Pcdhg* mutant allele, but not Cre, show robust expression of GFP in the MGE. In contrast, in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice (at E13.5; bottom panels), carrying the *Pcdhg* mutant allele and expressing Cre, GFP expression was eliminated from the MGE. Note NKX2.1 staining (magenta) in the panels on the right delineates MGE/POA (preoptic area). The few cells left expressing GFP in the MGE are blood vessels and are tdTomato negative. (**C**) Photographs of coronal sections of the primary visual cortex (V1) in *Nkx2.1^Cre^;*Ai14*;Pcdhg*^+/+^ (*Pcdhg* WT), *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/+^* (*Pcdhg* HET) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant). Scale bar, 100 μm. (**C'**) Quantification of the density of tdTomato+ cells in V1 and S1BF cortex of P30 *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black), *Pcdhg* HET (grey) and *Pcdhg* mutant (magenta) mice. The number of Nkx2.1-derived cells was significantly reduced in *Nkx2.1^Cre^;*Ai14*;Pcdhg* mutant mice compared to WT controls(Kruskal-Wallis test; for V1(P value=0.002), for S1BF (P value=0.0065), adjusted p values \*p=0.0232, \*\*p=0.0168 (S1), n = 4--6 mice of each genotype). (**D**) Body weight and cortex thickness measurements in *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black) and *Pcdhg* mutant (magenta) mice at P30. Body weight and cortical thickness were not significantly affected by loss of *Pcdhg *(Mann-Whitney test, body weight (p=0.0547, n = 10 mice of each genotype), cortical thickness (p=0.2857, n = 4--5 mice of each genotype). (**E**) Quantification of tdTomato+ cIN subtypes in V1 mouse cortex at P30. *Nkx2.1^Cre^;*Ai14*;Pcdhg* mutant mice (magenta) had significantly reduced numbers of MGE-derived parvalbumin (PV)+, somatostatin (SST)+, and Reelin (RLN)+ cells compared to WT controls. In contrast VIP+ cells, which are derived from the CGE, were not significantly affected (Kruskal-Wallis test; for PV (P value = 0.0113), for SST (P value=0.0009), for RLN (P value = 0.0014), and for VIP (P value=0.636); adjusted p values \*p=0.0113 (PV), \*\*p=0.0055 (SST), \*\*p=0.0055 (RLN), n = 4--5 mice of each genotype).\
Figure 3---source data 1.Quantification of Nkx2.1-derived cINs, body weight and cortical thickness measurements in controls and *Pcdhg-*deficient mice.](elife-55374-fig3){#fig3}

The developmental defects observed in *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mutant mice may indirectly affect the survival of cINs in a non-cell autonomous manner. We thus decided to restrict the *Pcdhg* loss of function to MGE/POA (preoptic area) progenitors by means of the *Nkx2.1^Cre^* mouse ([@bib74]). MGE/POA progenitors give rise to the majority of mouse cINs, including PV and SST interneurons. NKX2.1 expression is detected in the ventral telencephalon from E9.5 ([@bib60]; [@bib62]) and is downregulated in most cINs as they migrate into the developing neocortex ([@bib50]). *Pcdhg^fcon3^* mice were crossed to *Nkx2.1^Cre^* mice. As described above, tdTomato expression was again used to visualize the recombined cells ([Figure 3A](#fig3){ref-type="fig"}). Homozygous *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* embryos lost GFP expression specifically in in the MGE and the preoptic regions ([Figure 3B](#fig3){ref-type="fig"}), consistent with full recombination and loss of *Pcdhg* function in cells derived from the Nkx2.1 lineage.

At P30, the number of MGE-derived tdTomato+ cells in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice was dramatically reduced (\~50%) in both the visual and somatosensory cortex ([Figure 3C and C'](#fig3){ref-type="fig"}). MGE-derived PV and SST interneuron number was similarly reduced in these animals. However CGE-derived VIP interneuron density was similar to that of control animals ([Figure 3E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). A smaller, but significant reduction in the RLN positive cIN population was observed, in agreement with the notion that a subpopulation of RLN cells is born in the MGE ([@bib46]). Consistently, layer 1 RLN+ cells, which are largely derived from the CGE ([@bib46]), were not affected by *Pcdhg* loss of function, but RNL cells in deeper layers 2--6 (many of which are MGE-derived and also positive for SST) showed reduced numbers ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Interestingly, we observed that in our *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice, the number of un-recombined PV and SST (PV+/tdTomato- and SST+/tdTomato-) cells was significantly increased compared to WT mice ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}), a result consistent with recent observations ([@bib7]). PV+/tdTomato- and SST+/tdTomato- cells are likely derived from the most dorsal MGE at the interface with LGE expressing NKX6.2 in a region of low, or no expression of NKX2.1 ([@bib28]; [@bib29]; [@bib18]; [@bib63]). We do not know if the presence of the conditional *Pcdhg^fcon3^* allele results in increased production of these cells or if un-recombined cells from this domain increase their survival in compensation for the loss of cINs that lack *Pcdhg* function. If the latter is true, the behavior of these un-recombined PV and SST cINs differs from that observed for WT cells co-transplanted with MGE cells lacking *Pcdhg* function (see below). Together the above results show that embryonic loss of *Pcdhg* function in Nkx2.1-positive progenitors results in a significant reduction in the number of MGE/POA-derived cINs.

*Pcdhg* function is not required for the proliferation and migration of cIN precursors {#s2-3}
--------------------------------------------------------------------------------------

The reduction in the number of cINs in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice was not a result of abnormal cortical thickness or abnormal layer distribution, as these measures were similar across genotypes in P30 mice ([Figure 3C](#fig3){ref-type="fig"}). Next, we asked whether migration or proliferation defects in the cIN progenitor population could lead to a reduced cIN density in *Pcdhg* mutant mice. Quantification of the number of dividing cells in the ventricular or subventricular zones at E13.5 and E15.5, using the mitotic marker Phosphohistone H3 (PH3), showed no difference in the number of mitotic cells in the MGE between *Nkx2.1^Cre^;*Ai14*; Pcdhg^fcon3/fcon3^* mice and controls ([Figure 4A and B](#fig4){ref-type="fig"}). Migration of young cINs into cortex was also not affected in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice . The tdTomato+ cells in the cortex displayed a similar migratory morphology in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* embryos and controls. Consistent with the absence of an effect of *Pcdhg* on cIN migration, the number of migrating cells in cortex in the marginal zone (MZ), the subplate (SP), and the intermediate and subventricular zone (IZ/SVZ) was equivalent between *Pcdhg* mutant embryos and controls at E15.5 ([Figure 4C and D](#fig4){ref-type="fig"}). These findings indicate that loss of *Pcdhg* did not affect the proliferation of MGE progenitors or the migration of young MGE-derived cINs into the developing neocortex.

![Proliferation and migration are not affected by the loss of *Pcdhg* in NKX2.1 expressing cells.\
( **A**) Photographs of coronal sections through the embryonic forebrains of E13.5 *Nkx2.1^Cre^;*Ai14*;Pcdhg*^+/+^ (*Pcdhg* WT, top panels) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, bottom panels). Close-up photographs of the MGE from *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (right panels) and *Pcdhg* mutant (bottom, right panels) embryos. Robust reporter activity (tdTomato) was observed in the MGE. Dividing cells were labeled using the mitotic marker PH3. Note that the size and number of PH3+ cells in the MGE was similar in the mutant and control brains. Scale bars, 50 μm. (**B**) Quantification of PH3+ cells from MGE ventricular (VZ) and subventricular zone (SVZ) in E13.5 (top) and E15.5 (bottom) *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black bars) and *Pcdhg* mutant (magenta bars) embryos (Mann-Whitney test, p=0.4000 (E13.5 VZ), p=0.8571 (E13.5 SVZ), p=0.8571 (E15.5 VZ), p\>0.999 (E15.5 SVZ), n = 3--4 embryos of each genotype). (**C**) Photographs of coronal sections of dorsal cortex at E15.5 showing the migrating MGE-derived cIN in *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (left) and *Pcdhg* mutant (right) embryos. Note the robust migratory streams of young neurons in the SVZ and in the marginal zone (MZ). From these regions, cells disperse into the intermediate zone (IZ) and cortical plate (CP). Similar numbers of migrating cIN were observed in mutants and controls. Scale bar, 100 μm. (**D**) Quantifications of number of migrating MGE-derived cINs in the CP and in the IZ/SVZ of *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black) and *Pcdhg* mutant (magenta) mice. No significant differences were detected in the number of tdTomato+ migrating cells in *Pcdhg* mutant and WT controls (Mann-Whitney test, p\>0.990 (E15.5 CP), p=0.7000 (E15.5 IZ-SVA), n = 3 embryos of each genotype).\
Figure 4---source data 1.Quantification of PH3 positive cells in the embryonic MGE and number of Nkx2.1-derived cINs in the embryonic dorsal cortex of controls and *Pcdhg* loss of function mice.](elife-55374-fig4){#fig4}

Accentuated cIN cell death in *Pcdhg* mutants {#s2-4}
---------------------------------------------

A wave of programmed cell death eliminates \~40% of the young cINs shortly after their arrival in the cortex ([@bib64]; [@bib71]). This wave starts at \~P0, peaks at P7, and ends at \~P15. Next, we asked if the reduced cIN density observed in *Pcdhg* mutant mice could stem from a heightened number of mutant cINs undergoing apoptosis at the normal time. Such cells were immunolabeled using an antibody directed against cleaved-Caspase 3 (CC3). Since CC3 positive cells are relatively rare, our analysis was performed throughout the entire neocortex, at P0, 3, 7, 10, and 15. Similarly to their wild type littermates, *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* homozygous mice displayed a wave of programmed cell death peaking at P7 ([Figure 5A and B](#fig5){ref-type="fig"}). However, *Pcdhg* mutant mice had significantly higher numbers of tdTomato+/CC3+ cells compared to controls. We also examined the proportion of CC3+ cells that were tdTomato negative (un-recombined cells that would notably include pyramidal cells, CGE-derived cINs, and glial cells). With the exception of a small, but significant increase observed at P0, we found no significant difference in the number of CC3+/tdTomato- cells between genotypes ([Figure 5B](#fig5){ref-type="fig"}, bottom graph). This suggests that the survival of neighboring *Pcdhg*-expressing cells is not impacted by the loss of *Pcdhg*-deficient MGE/POA-derived cINs. Importantly, the homozygous deletion of the pro-apoptotic Bcl-2-associated X protein (BAX) rescued cIN density in the *Pcdhg* mutant mice to levels similar to those observed in control *Bax^-/-^ ;Pcdh^fcon3/+^* mice or in mice carrying only the *Bax* mutation (*Bax^-/-^*) ([@bib64]; [Figure 5C](#fig5){ref-type="fig"}). The above results indicate that loss of *Pcdhg* in MGE/POA-derived cIN enhances their demise through programmed cell death during the developmental period when these cells are normally eliminated.

![Increased programmed cell death in *Pcdhg* mutants is rescued in *Pcdhg-bax* null animals.\
(**A**) Photographs of coronal sections through a *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) P7 mouse cortex (top), showing tdTomato+ cINs and cleaved caspase 3 positive cells (CC3+). Close-up photographs (bottom) of tdTomato+, CC3+ (white Arrowheads) and tdTomato-, CC3+ (blue Arrowheads) cells. Scale bar 25 μm. (**B**) Quantification of the density of tdTomato+,CC3+ (MGE-derived, top graph) cells from *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black line) and *Pcdhg* mutant (magenta line) mice. Quantification of the density of tdTomato-,CC3+ (non-MGE-derived, bottom graph) cells from *Nkx2.1^Cre^;*Ai14*;Pcdhg* WT (black line) and *Pcdhg* mutant (magenta line) mice. Note that the number of CC3+ cells was significantly increased in the MGE-derived population in *Pcdhg* mutant mice, and coincides with the normal period of programmed cell death for cINs in WT mice (Each age was analyzed with a nested 1-way ANOVA (mouse ID nested within genotype), P value\<0.0001. Significant comparisons are marked with \*; \*p=0.0004 \*\*p=0.0014, \*\*\*p=0.0009, n = 3--5 mice of each genotype). (**C**) Coronal sections through the primary visual cortex (V1) of *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, left) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^;Bax^-/-^* (*Pcdhg* mutant, *Bax* null, right) mice at P30. Quantifications of the density of cINs in V1 (top) and S1BF (bottom) cortex. Note that genetic removal of *Bax* in both *Pcdhg^fcon3/+^* (*Pcdhg* HET) and *Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) mice rescues cell death to similar levels (Kruskal-Wallis test, P value\<0.001 (for V1 an S1BF), adjusted p values for V1 (\*p=0.01 , \*\*0.005 ) and for S1BF (\*\*p=0.0109 , \*p=0.0286); n = 4--5 mice of each genotype).\
Figure 5---source data 1.Analysis of cIN programmed cell death in controls, *Pcdhg* mutant and *Bax* null mice.](elife-55374-fig5){#fig5}

Loss of *Pcdhg* does not affect survival of cINs after the period of programmed cell death {#s2-5}
------------------------------------------------------------------------------------------

We then asked whether *Pcdhg*-expression is also required for the survival of cINs past the period of programmed cell death. To address this question we took advantage of the *PV^Cre^* transgene ([@bib26]) that becomes activated specifically in PV interneurons starting at around \~P16 ([Figure 6](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Quantifications of tdTomato+ cell density in *PV^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* and *PV^Cre^;*Ai14 mice at P60-P100 revealed no significant differences between homozygous and control mice (V1 and S1BF) ([Figure 6D and E](#fig6){ref-type="fig"}). In contrast, the *Sst^Cre^* line, like *Nkx2.1^Cr^*^e^, induces recombination at embryonic stages. The *Sst^Cre^* allele in Ai14*; Pcdhg^fcon3/fcon3^* reduced the density of SST interneurons measured at P30 to the same level as was found using the *Nkx2.1^Cre^* line ([Figure 6A--C](#fig6){ref-type="fig"}). Together, our results demonstrate that *Pcdhg* loss of function reduces cIN survival specifically during the endogenous period of cIN cell death, resulting in a reduced cortical density of cINs.

![*Pcdhg* function is not required for the survival of PV cINs after the period of programmed cell death.\
(**A**) Mutant mice with loss of *Pcdhg* in SST or PV cells were generated by crossing conditional *Pcdhg^fcon3^* mice to mice carrying Cre under *Sst (Sst^Cre^)* or *Pvalb* (Parvalbumin, *PV^Cre^*). The conditional Ai14 line was used to fluorescently label SST or PV cells. (**B**) Photographs of coronal sections of the primary visual cortex (V1) of P30 *Sst^Cre^;* Ai14*;Pcdhg^+/+^* (*Pcdhg* WT, top left) and *Sst^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, bottom left) mice. Scale bars, 50 μm. (**C**) Quantifications of the density of tdTomato+ cINs in V1 cortex of *Pcdhg* WT (black) and *Pcdhg* mutant (magenta) *Sst^Cre^;*Ai14 mice at P30 (Mann-Whitney test, \*\*p=0.0286, n = 4 mice of each genotype). (**D**) Photographs of coronal sections of V1 in *PV^Cre^;*Ai14*;Pcdhg^+/+^* (*Pcdhg* WT, top right) and *PV^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, bottom right) mice at P60. Scale bars, 50 μm. (**E**) Quantifications of the density of tdTomato+ cIN in V1 cortex of *Pcdhg* WT and *Pcdhg* mutant *PV^Cre^;*Ai14 mice at P60-100 (Mann-Whitney test, p=0.4206,n = 5 mice of each genotype).\
Figure 6---source data 1.Analysis of PV and SST- derived cINs at P30 in controls and *Pcdhg* mice.](elife-55374-fig6){#fig6}

*Pcdha* and *Pcdhb* do not affect cIN survival {#s2-6}
----------------------------------------------

Previous studies indicate that Pcdhs form tetrameric units that include members of the alpha, beta, and gamma clusters ([@bib61]; [@bib3]). We, therefore asked whether *Pcdha* and *Pcdhb* genes also contribute to cIN cell death. Mice that carry a conditional deletion of the entire alpha cluster (*Pcdha^acon/acon^*) were crossed to the *Nkx2.1^Cre^;*Ai14 line, resulting in removal of the *Pcdha* genes specifically from MGE/POA progenitor cells ([Figure 7A](#fig7){ref-type="fig"}). *Nkx2.1^Cre^;*Ai14*;Pcdha^acon/acon^* mice were viable, fertile, and displayed normal weight ([Figure 7B](#fig7){ref-type="fig"}, top graph). cIN density in the visual cortex of *Nkx2.1^Cre^;*Ai14*;Pcdha^acon/aco^*^n^ mice at P30 was similar to that of *Nkx2.1^Cre^;*Ai14 mice ([Figure 7B](#fig7){ref-type="fig"}). To determine whether *Pcdhb* genes affected MGE/POA-derived cIN survival, constitutive *Pcdhb gene* cluster knockout (*Pcdhb^del/del^*) mice were crossed to *Nkx2.1^Cre^;*Ai14 mice ([Figure 7A](#fig7){ref-type="fig"}). Mice carrying a deletion of the entire *Pcdhb* cluster were viable, fertile and of normal weight ([Figure 7C](#fig7){ref-type="fig"}, top graph) ([@bib11]). The density of cINs was similar between mice lacking *Pcdhb* and controls ([Figure 7C](#fig7){ref-type="fig"}). The above results indicate that unlike the *Pcdhg* cluster, which is essential for the regulation of cIN elimination, the function of *Pcdha* or *Pcdhb* is dispensable for the survival of MGE/POA-derived cINs.

![Loss of *Pcdha*, *Pcdhb*, or *Pcdhga1, Pcdhga2, and Pcdhga3* genes does not affect the survival of MGE-derived cINs.\
(**A**) Mutant mice with loss of *Pcdha*, *Pcdhb* or *Pcdhga1, Pcdhga2, and Pcdhga3* genes in MGE-derived cINs were generated by crossing *Pcdha*^acon^, *Pcdhb^del^*, and *Pcdhg^tako^* mice to the *Nkx2.1^Cre^* mouse line. The conditional Ai14 line was used to fluorescently label MGE-derived cells. (**B**) Measurements of body weight (top graph) in P30 *Nkx2.1^Cre^;*Ai14*;Pcdha*^+/+^ (*Pcdha* WT, black bar) and *Nkx2.1^Cre^;*Ai14*;Pcdha*^acon/acon^ (*Pcdha* mutant, grey bar) mice (Mann-Whitney test, p=0.545, n = 9--14 mice of each genotype). Quantification of the density of MGE-derived cINs (bottom graph) in primary visual cortex (V1) of *Pcdha* WT (black bar) and *Pcdha* mutant (grey bar) P30 mice (Mann-Whitney test, p=0.9603, n = 4--5 mice of each genotype). (**C**) Measurements of body weight (top bar) in P30 *Nkx2.1^Cre^;*Ai14*;Pcdhb^+/+^* (*Pcdhb* WT, black bar) and *Nkx2.1^Cre^;*Ai14*;Pcdhb^del/de^*^l^ (*Pcdhb* mutant, pink bar) mice (Mann-Whitney test, p=0.712, n = 4--9 mice of each genotype). Quantification of the density of MGE-derived cIN (bottom graph) in primary visual cortex (V1) of *Pcdhb* WT (black bar) and *Pcdhb* mutant (pink bar) P30 mice (Mann-Whitney test, p=0.1111, n = 4--5 mice of each genotype). (**D**) Measurements of body weight (top graph) in *Nkx2.1^Cre^;*Ai14*;Pcdhg*^+/+^ (*Pcdhg* WT, black) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^tako/tako^*(*Pcdhga1, Pcdhga2, and Pcdhga3* mutant, blue bar) P30 mice (Mann-Whitney test, p=0.175, n = 4--5 mice of each genotype). Quantification of the density of MGE-derived cINs (bottom graph) in in primary visual cortex (V1) of *Pcdhg* WT (black bar) and *Pcdhga1, Pcdhga2, and Pcdhga3* mutant (blue bar) P30 mice (Mann-Whitney test, p=0.9048, n = 4--5 mice of each genotype).\
Figure 7---source data 1.Analysis of Nkx2.1-derived cINs in P30 control, *Pcdha*, *Pcdhb* and *Pcdhg* mutant mice.](elife-55374-fig7){#fig7}

Loss of *Pcdhg* does not affect cIN dispersion after transplantation but affects their survival {#s2-7}
-----------------------------------------------------------------------------------------------

In order to compare the timing and extent of migration, survival, and maturation of cINs of different genotypes within the same environment, we co-transplanted into the cortex of host animals, MGE-derived cIN precursor cells expressing red and green fluorescent proteins. MGE cIN precursors were derived from E13.5 *Gad1*-GFP embryos (*Pcdhg* WT controls) or from *Nkx2.1^Cre^;*Ai14 embryos that were either *Pcdhg* WT or *Pcdhg* mutant ([Figure 8A](#fig8){ref-type="fig"}). We first confirmed that MGE cells WT for *Pcdhg*, but carrying the two different fluorescent reporters, displayed no differences in their survival. Equal proportions of *Gad1*-GFP cells (*Pcdhg* WT GFP+) and *Nkx2.1^Cre^;*Ai14 cells (*Pcdhg* WT tdTomato+) were co-transplanted into the neocortex of neonatal recipients. While equivalent numbers of red and green cells were mixed before being transplanted, the absolute number of cells transplanted varied from transplant to transplant. In order to compare the survival, we use the fraction of green or red cells, among all co-transplanted cells (red + green). The fraction of surviving GFP+ and tdTomato+ cells at 3, 6, 13, and 21 days after transplantation (DAT) was measured ([Figure 8A and B](#fig8){ref-type="fig"}, top graph). The contribution of each cell population to the overall pool of surviving cells was found to be \~50% at 3 DAT, and remained constant at 6, 13, and 21 DAT ([Figure 8B](#fig8){ref-type="fig"}, top graph). This experiment indicates that the fluorescent reporters (GFP or tdTomato) or breeding background does not affect the survival of MGE cINs in this assay. Next, we co-transplanted equal numbers of *Gad1*-GFP cells (*Pcdhg* WT) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* cells (*Pcdhg* mutant) into the cortex of WT neonatal recipients. As above, we measured the proportion of surviving GFP+ and tdTomato+ cells at 3, 6, 13, and 21 DAT ([Figure 8A](#fig8){ref-type="fig"}). Similar numbers of GFP+ and tdTomato+ cells were observed at 3 and 6 DAT. However, the fraction of *Pcdhg* mutant cINs (tdTomato+) surviving was dramatically lower when the transplanted cells reached a cellular age equivalent to that of endogenous cINs after the normal wave of programmed cell death (6DAT is roughly equivalent to P0; 21DAT is roughly equivalent to P15) ([@bib64]). Note that in this experiment the proportion of WT cells increases during this same period. This change in proportion is not a reflection of increased survival, as these cells also undergo elimination by programmed cell death (see below) ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), but that, with the increased loss of mutant cells, the WT cells account for a larger fraction of the total.

![*Pcdhg* are required for cIN survival after transplantation.\
(**A**) Schematic of co-transplantation of MGE-derived cIN precursors. MGE cells were derived from *Nkx2.1^Cre^;*Ai14*;Pcdhg^+/+^* (*Pcdhg* WT) or *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) embryos. These cells were mixed in equal proportions with MGE cells from *Gad1*-GFP embryos (*Pcdhg* WT, green) and transplanted into WT black (Blk) six host recipient mice. Cell survival was analyzed before (3 DAT) and throughout the period of cell death (6--21 DAT). (**B,B'**) Survival fraction of co-transplanted MGE-derived cIN precursors. (**B**) MGE cells were derived from *Gad1*-GFP (green) and *Nkx2.1^Cre^;*Ai14; (magenta) embryos; both GFP+ and tdTomato+ cells carry WT *Pcdhg*. In this control experiment the survival fraction was similar for both genotypes carrying the different fluorescent reporters (2-way ANOVA, F~genotype~ = 2.54, P value \> 0.999; n = 4--6 mice per time point from two transplant cohorts). (**B'**) MGE cells were derived from *Gad1*-GFP WT (green) and *Nkx2.1^Cre^;*Ai14*;Pcdhg* mutant (magenta) embryos. GFP+ and tdTomato+ cells showed dramatic differences in their survival; the majority of cells carrying the *Pcdhg* mutant allele (magenta) were eliminated between 6 and 21 DAT (2-way ANOVA, F~genotype~ = 2738.02, P value \< 0.0001; adjusted p values \*\*\*p\<0.0001; n = 4--5 mice per time point from two transplant cohorts. Quantifications in (**B and B'**) were done at 3, 6, 13 and 21 DAT and are represented as fractions of GFP+ or tdTomato+ cells from total cells (GFP + tdTomato+) per brain section. The increase in the proportion of WT cells during this period is not a reflection of increased cell numbers (WT cIN also undergo elimination by programmed cell death (See [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), but rather that WT cells account for a larger fraction of all transplant-derived cells (WT + *Pcdhg* mutant). (**C**) Representative photographs of cortical sections from transplanted host mice at 6 (left) and 21 (right) DAT. Transplanted MGE cells were derived from *Gad1*-GFP (*Pcdhg* WT, green) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, red) embryos. Scale bars, 50 μm.\
Figure 8---source data 1.Survival of transplanted MGE-derived cIN precursor cells carrying WT or mutant *Pcdhg*.](elife-55374-fig8){#fig8}

We next determined whether the survival of *Pcdhg* WT (GFP+) or *Pcdhg* mutant (tdTomato+) cINs was affected by their density ([Figure 9](#fig9){ref-type="fig"}). At 6 DAT, WT and *Pcdhg* mutant MGE-derived cells had migrated away from the injection site establishing a bell-shaped distribution of density as a function of tangential distance from the injection site ([Figure 9B and B'](#fig9){ref-type="fig"}). The dispersion of developing cINs lacking *Pcdhg* was indistinguishable from that of control WT cells at this time (Figure B', top graph), consistent with our observation that *Pcdhg* expression is not required for the migration of MGE-derived cINs. Strikingly, the survival fraction at 6 DAT of control *Pcdhg* WT (GFP+) and *Pcdhg* mutant (*Nkx2.1^Cre^;*Ai14 *;Pcdhg^fcon3/fcon3^*) cINs at the injection site or at multiple locations anterior or posterior to the site of injection were also similar ([Figure 9B'](#fig9){ref-type="fig"}, bottom graph). By 21 DAT the survival of *Pcdhg* mutant (*Nkx2.1^Cre^;*Ai14 *;Pcdhg^fcon3/fcon3^*) cells was dramatically reduced, and to a similar extent at all distances from the injection site ([Figure 9B and B'](#fig9){ref-type="fig"}). Since the density of cIN varies fivefold over regions measured, we conclude that the survival of control *Pcdhg* WT and *Pcdhg* mutant cIN does not depend on their density over this range.

![Survival of cIN, WT or mutant for *Pcdhg*, was not affected by cell density.\
(**A**) MGE cells derived from *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* embryos (*Pcdhg* mutant, magenta) and from *Gad1*-GFP embryos (*Pcdhg* WT, green) were mixed in equal numbers and transplanted into WT hosts. The survival of tdTomato and GFP- labeled cINs was analyzed in every other section throughout the brain region of the transplant dispersal. (**B**) Photographs of representative coronal sections at the injection site, or anterior and posterior to it, from host mice at 6DAT. Similar numbers of tdTomato and GFP-labeled cINs were observed at each location. Scale bar 100 μm. (**B'**) Dispersion analysis at 6 DAT of the *Pcdhg* WT (green) or *Pcdhg* mutant (magenta) cells, represented as density (top) or survival fraction (bottom) as a function of distance from the site of injection in the host recipients. Note that the density of cells decreases as one moves anteriorly or posteriorly with respect to the injection site. At 6 DAT, the dispersal and survival was similar for both WT and *Pcdhg* mutant cells. (**C**) Photographs of representative coronal sections at the injection site, or anterior and posterior to it, from host mice at 21DAT. Note the dramatic reduction in the number of *Pcdhg* mutant cells (magenta) compared to the *Pcdhg* WT cells (green). Scale bar 100 μm. (**C'**) Dispersion analysis at 21DAT of the *Pcdhg* WT (green) or *Pcdhg* mutant (magenta) cells, represented as density (top) or survival fraction (bottom) as a function of distance from the site of injection in the host recipients. At 21 DAT, the survival fraction for the *Pcdhg* mutant cells (magenta) was dramatically reduced and similarly affected at different locations with respect to the injection site.\
Figure 9---source data 1.Dispersal and survival analysis of transplanted MGE-derived cIN precursor cells carrying WT or mutant *Pcdhg*.](elife-55374-fig9){#fig9}

In order to determine the absolute number of cINs eliminated in our co-transplantation experiments, we co-transplanted 50 K cells of each genotype (*Pcdhg* WT and *Pcdhg* mutant) into WT host mice ([Figure 10A](#fig10){ref-type="fig"}). Our baseline for survival was established at 6 DAT, before the period of cIN programmed cell death. In control experiments where cIN precursors WT for the *Pcdhg* allele, derived from *Nkx2.1^Cre^;*Ai14 or *Gad1-GFP* embryos, were transplanted, 39% of the transplanted cIN population was eliminated between 6 and 21 DAT ([Figure 10A--C](#fig10){ref-type="fig"} and [Figure 10---figure supplement 1](#fig10s1){ref-type="fig"}). Therefore, transplanted MGE cINs not only undergo programmed cell death during a period defined by their intrinsic cellular age but are also eliminated in a proportion that is strikingly similar to that observed during normal development ([@bib71]; [@bib64]). Given these observations, we next asked how the presence of *Pcdhg* mutant cIN affected the survival of WT cIN in the transplantation setting. We co-transplanted 50K *Gad1-*GFP *Pcdhg* WT (GFP+) with 50K *Nkx2.1^Cre^;*Ai14 *Pcdhg* mutant (tdTomato+) MGE cIN precursors and compared the survival of each population at 6 and 21 DAT. At 6 DAT the total number of tdTomato+ cells in the cortex of recipient mice was similar to that of GFP+ cells ([Figure 10A,D and E](#fig10){ref-type="fig"}). However, between 6 and 21DAT, the total number of GFP+ cells had decreased by an average of \~63% ([Figure 10E](#fig10){ref-type="fig"}, compared to [Figure 10C](#fig10){ref-type="fig"}). Compared to the \~40% of endogenous or transplanted WT cINs that are normally eliminated (present study and previous work [@bib64]; [@bib71]), this experiment suggests that WT cells die at a higher rate (63%) when co-transplanted with *Pcdhg* mutant MGE cells. However, this observation would require additional animals for statistical confirmation. Regardless, the number of *Pcdhg* mutant (tdTomato+ cells) cINs decreased dramatically, by \~96% ([Figure 10E](#fig10){ref-type="fig"}). This experiment confirms that MGE cells lacking *Pcdhg* function are eliminated in far greater numbers than control MGE cells and show that the presence of *Pcdhg* WT cINs within a mixed population also affects the survival of mutant cINs (compare [Figure 8](#fig8){ref-type="fig"} and [Figure 10](#fig10){ref-type="fig"}). These observations are consistent with the hypothesis that cINs interact with others of the same age discussed below.

![MGE cell transplantation reveals a non-cell autonomous effect of *Pcdhg* on cIN survival.\
(**A**) Schematic of co-transplantation experiment for quantification of absolute number of transplanted MGE cells derived from (1) *Nkx2.1^Cre^;*Ai14 and *Gad1*-GFP embryos WT for *Pcdhg* or (2) *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, magenta) and *Gad1*-GFP (*Pcdhg* WT, green) embryos. The total numbers of transplant-derived cINs were counted at 6 and 21 DAT throughout the volume of cortex were transplanted cells dispersed. (**B**) Photographs of representative coronal sections of co-transplanted tdTomato and GFP-labeled cells, both *Pcdhg* WT, at 6 and 21 DAT. Scale bar 100 um. (**C**) Absolute number of surviving tdTomato and GFP-labeled *Pcdhg* WT cIN at 6 and 21 DAT (top graph) (Mann-Whitney test, \*\*p=0.0286, n = 4 mice per time point from one transplant cohort). The drop in number of transplant derived cells was similar for WT-GFP+ and WT-tdTomato+ ([Figure 10---figure supplement 1](#fig10s1){ref-type="fig"}). A 39% drop in cIN number was observed between 6 and 21 DAT (bottom graph). (**D**) Photographs of representative coronal sections of transplanted tdTomato-labeled *Pcdhg* mutant (magenta) and GFP-labeled *Pcdhg* WT (green) cells at 6 and 21 DAT. Survival of the cINs drops for both genotypes, but the tdTomato-labeled cells were nearly eliminated by 21 DAT. Scale bar 100 μm. (**E**) Absolute number of surviving cINs at 6 and 21 DAT (top graph)(2-way ANOVA; F~age~ = 128.65, P value \< 0.0001, adjusted p value \*\*\*\*p\<0.0001); F~genotype~ = 9.74 (p value=0.0066, adjusted p value \*p=0.0126); n = 5 mice per time point from one transplant cohort). Comparing 6 and 21 DAT a drop of \~63% and of 96.0% was observed, respectively, for cells WT and mutant for *Pcdhg* (bottom graph).\
Figure 10---source data 1.Survival analysis and absolute quantification of transplanted MGE-derived cIN precursor cells carrying WT or mutant *Pcdhg*.](elife-55374-fig10){#fig10}

Loss of *Pcdhg* isoforms *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* is sufficient to increase cell death {#s2-8}
-------------------------------------------------------------------------------------------------

The results above indicate that the loss of function of all 22 Pcdh isoforms encoded from the *Pcdhg gene* cluster significantly increased cell death among cINs. Whether all 22 *Pcdhg* are equally involved in the regulation of cIN survival remains unclear. Our qPCR expression analysis suggests that the expression of *Pcdhga1*, *Pcdha2*, *Pcdhgc4* and *Pcdhgc5* in cINs increases during, or soon after, the period of cell death ([Figure 1C](#fig1){ref-type="fig"}). To test if *Pcdhga1, Pcdhga2, and Pcdhga3* were required for the normal survival of MGE-derived cINs, we crossed the *Pcdhg^tako^*^/*tako*^ mouse line (*Pcdhga1, Pcdhga2, and Pcdhga3 isoform KO*) to *Nkx2.1^Cre^;* Ai14 mice ([Figure 7A](#fig7){ref-type="fig"}). At P30, the density of cINs in visual cortex of *Nkx2.1^Cre^;*Ai14;*Pcdhg^tako^*^/*tako*^ (*Pcdhga1, Pcdhga2, and Pcdhga3* mutant) mice was not significantly different from that of control *Nkx2.1^Cre^;*Ai14 mice that are WT for *Pcdhg* ([Figure 7D](#fig7){ref-type="fig"}). Consistent with this finding, co-transplanted E13.5 *Nkx2.1^Cre^;* Ai14;*Pcdhg^tako^*^/*tako*^ MGE cells and *Pcdhg* WT (GFP+) displayed surviving fractions of similar sizes ([Figure 11A,B & B'](#fig11){ref-type="fig"}). Therefore, the removal of the first three isoforms (*Pcdga1, Pcdhga2 and Pcdhga3*) of the *Pcdhg* cluster does not significantly affect cIN survival.

![Loss of *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* is sufficient to increase cIN cell death.\
(**A**) Diagram of the mutant alleles *Pcdhg^tako^* (*Pcdhga1, Pcdhga2, and Pcdhga3* KO) and *Pcdhg^tcko^* (*Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* KO). Below - schematic of transplantation of MGE cIN precursors from *Nkx2.1^Cre^;*Ai14*;Pcdhg^tako/tako^* (*Pcdhga1, Pcdhga2, and Pcdhga3* deleted) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^tcko^*^/*tcko*^ (*Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* deleted) embryos. These cells were mixed in equal proportions with MGE cells from *Gad1*-GFP embryos (*Pcdhg* WT, green) and transplanted into WT Blk6 host recipients. Survival of the GFP and tdTomato-labeled cells was analyzed at 6 and 21 DAT. (**B, B'**) Representative photographs of cortical sections from transplanted host animals at 6 (left) and 21 (right) DAT. Note the similar proportions of *Pcdhg* WT (GFP+) and *Pcdhga1, Pcdhga2, and Pcdhga3* deleted cells (tdTomato+) at 6 and 21DAT. Scale bars, 100 μm. (**B'**) Quantifications of the survival fraction of the GFP (green) and tdTomato (magenta)-labeled MGE-derived cells at 6 and 21 DAT. Note, survival fraction remains similar and constant for both genotypes (*Pcdhg* WT and *Pcdhga1, Pcdhga2, and Pcdhga3* deleted cells) between 6 and 21 DAT (Mann-Whitney test, p=6571, n = 4 mice per time point from one transplant cohort). (**C, C'**) Representative photographs from coronal brain sections of transplanted host animals at 6 (left) and 21 (right) DAT. Scale bars, 100 μm. Survival of MGE-derived cINs from *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* deleted embryos (tdTomato+) is markedly different from MGE-derived cINs from *Pcdhg* WT embryos (GFP+). (**C'**) Survival fraction at 6 and 21 DAT of the *Pcdhg* WT (green) and *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* deleted cells (magenta) (Mann-Whitney test, \*\*\*\*p=0.0286, n = 4 mice per time point from one transplant cohort).\
Figure 11---source data 1.Survival analysis of transplanted MGE-derived cIN precursor cells deficient in *Pcdha1*, *Pcdha2 and Pcdha3 or deficient in Pcdhc3, Pcdhc4 and Pcdhc5.*](elife-55374-fig11){#fig11}

We next tested if removal of the last three isoforms of the *Pcdhg* cluster (*Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5*) affected cIN survival. *Pcdhg^tcko/+^* mice, heterozygous for excision of *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* were crossed to the *Nkx2.1^Cre^;*Ai14 mouse line to label MGE/POA-derived cINs ([Figure 11A](#fig11){ref-type="fig"}). Even though homozygous *Nkx2.1^Cre^;*Ai14 *;Pcdhg^tcko/tcko^* mice develop normally (normal weight and no evidence of brain abnormalities) and are born in normal Mendelian ratios, these mice die shortly after birth ([@bib10]). To bypass neonatal lethality, and study the role of *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms during the normal period of cIN programmed cell death, we co-transplanted *Pcdhg^tcko/tcko^* (tdTomato+, mutant) and *Pcdhg* WT (GFP+) E13.5 MGE cells into the cortex of WT neonatal recipients ([Figure 11A](#fig11){ref-type="fig"}). At 6 DAT, the dispersion and density of tdTomato+ and GFP+ cells were indistinguishable. However, the number of tdTomato+ MGE-derived *Pcdhg^tcko/tcko^* mutant cINs dropped dramatically between 6 and 21 DAT, compared to the *Pcdhg* WT (GFP+) population ([Figure 11C](#fig11){ref-type="fig"}). The survival of *Pcdhg^tcko/tcko^* mutant cIN at 21 DAT was strikingly similar to that observed after transplantation of MGE cells lacking the entire *Pcdhg* cluster (*Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^*); compare [Figure 8](#fig8){ref-type="fig"} and [Figure 11](#fig11){ref-type="fig"}. These results indicate that unlike *Pcdga1, Pcdhga2 and Pcdhga3* isoforms*, Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* are essential for cIN survival.

Morphological and physiological maturation of cINs lacking *Pcdhg* {#s2-9}
------------------------------------------------------------------

The above results indicate that cINs lacking *Pcdhg* genes have increased cell death, specifically when the transplanted cells reach an age equivalent to that of endogenous cINs undergoing their normal period of programmed cell death. We therefore asked whether the loss of *Pcdhg* in cINs affected their morphological maturation during this period. We first determined the survival fraction for co-transplanted control *Gad1*-GFP (*Pcdhg* WT) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) MGE-derived cIN precursors at two-day intervals during the intrinsic period of cIN cell death in the transplanted population (6, 8, 10 and 12 DAT). When equal proportions of *Pcdhg* WT and *Pcdhg* mutant cells were co-transplanted, their survival fraction remained similar up to 6 DAT, but the proportion of the *Pcdhg* mutant cells dropped steadily throughout the period of cell death ([Figure 12B](#fig12){ref-type="fig"}). Morphological reconstructions of the transplanted cells during this period of cIN programmed cell death ([Figure 12A](#fig12){ref-type="fig"}) revealed no obvious differences between *the Pcdhg* mutant and control *Pcdhg* WT cells in neuritic complexity, including neurite length ([Figure 12C](#fig12){ref-type="fig"}), the number of neurites ([Figure 12D](#fig12){ref-type="fig"}), number of nodes ([Figure 12E](#fig12){ref-type="fig"}) and number of neurite ends ([Figure 12F](#fig12){ref-type="fig"}). These results suggest that *Pcdhg* genes do not play a major role in the morphological maturation of cINs during the period of cIN death.

![Loss of *Pcdhg* does not affect the morphological maturation of cIN during the period of programmed cell death.\
(**A**) Photographs of representative images and morphological reconstructions of co-transplanted *Gad1*-GFP cells (*Pcdhg* WT, left columns) with *Nkx2.1^Cre^*;Ai14*;Pcdhg^fcon3/fcon3^* cells (*Pcdhg* mutant, right columns) at 6, 8, 10 and 12DAT. Scale bars, 50 μm. (**B**) Quantifications of *Pcdhg* WT(green) and *Pcdhg* mutant cells (magenta) from co-transplanted animals, represented as survival fraction from total number of cells per section at 6, 8 10 12 and 21 DAT. *Pcdhg* mutant cells begin to increase their elimination between 6 and 8 DAT and this increased death occurs through 21 DAT. (**C--F**) Measurements of neurite complexity during the period of programmed cell death, including neurite length (**C**), neurite number (**D**), node number (**E**) and neurite ends (**F**) in *Pcdhg* WT(green) and *Pcdhg* mutant (magenta) neurons at 6, 8, 10 and 12 DAT. Two-tailed unpaired *Student's t-test*, n = 32 (WT), n = 35 (*Pcdhg* mutant) cells at 6 DAT, n = 27 (WT and *Pcdhg* mutant) cells at 8 DAT, n = 26 (WT), n = 27 (*Pcdhg* mutant) cells at 10 DAT, and n = 27 (WT), n = 31 (*Pcdhg* mutant) cells at 12 DAT; cells analyzed from two transplant cohorts. All statistical comparisons were not significant following Benjamini-Hochberg multiple comparisons correction at alpha of 0.05.\
Figure 12---source data 1.Morphological reconstruction of transplanted MGE-derived cIN precursor cells carrying WT or mutant *Pcdhg*.](elife-55374-fig12){#fig12}

Next, we utilized co-transplantation of cINs that were either *Pcdhg*-deficient (*Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^*) or WT (*Gad1*-GFP) to investigate whether the loss of *Pcdhg* affected the integration or intrinsic physiological properties of these cells at time points around the peak of *Pcdhg*-mediated cell death. To test how integration was affected, we made acute cortical slices of mouse visual cortex at 8, 9, 10, 11, and 12 DAT and measured the frequency of spontaneous excitatory (glutamatergic) and inhibitory (GABAergic) synaptic events, comparing mutant and WT cINs within the same slice. There was no effect of *Pcdhg* loss of function on the frequency of spontaneous excitatory (glutamatergic) synaptic events or on the frequency of spontaneous inhibitory (GABAergic) synaptic events ([Figure 13B](#fig13){ref-type="fig"} and [Tables 1](#table1){ref-type="table"} and [2](#table2){ref-type="table"}). We next investigated whether the loss of *Pcdhg* function altered intrinsic physiological properties in co-transplanted cINs. There was no effect of the loss of *Pcdhg* on the maximum firing rate ([Figure 13C](#fig13){ref-type="fig"} and [Tables 1](#table1){ref-type="table"} and [2](#table2){ref-type="table"}), membrane time constant (Tau) ([Figure 13D](#fig13){ref-type="fig"} and [Table 1](#table1){ref-type="table"}), or input resistance ([Figure 13F](#fig13){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). A difference in capacitance was observed between WT and *Nkx2.1^Cre^;*Ai14 *;Pcdhg^fcon3/fcon3^* cINs at 8DAT, but this difference was not statistically significant following multiple comparisons correction and was not seen at later time points ([Figure 13E](#fig13){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). We conclude that the synaptic integration and morphological - functional maturation of cINs lacking *Pcdhg* is similar to that of WT controls.

![*Pcdhg* deletion does not affect the physiological properties of cINs during the period of programmed cell death.\
(**A**) DIC image with fluorescence image overlaid showing co-transplanted cINs from the MGE of *Gad1*-GFP (*Pcdhg* WT, green) or *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, red) embryos, recorded in an acute brain slice taken from visual cortex (scale bar 10 µm). (**Ba**) Representative voltage clamp recordings (1 s) from a *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant) cINs held at −70 mV (top) to record glutamatergic events (orange circles) and 0 mV (bottom) to record GABAergic events (cyan circles). Bb, Bc. Group data from cINs recorded at 8, 9, 10, 11, and 12 DAT showing that co-transplanted *Gad1*-GFP cINs (WT, green circles) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* cINs (*Pcdhg* mutant, magenta circles) have similar rates of glutamatergic events (measured at −70 mV, **Bb**) and similar rates of GABAergic events (measured at 0 mV, **Bc**). The voltage clamp recordings from (**Ba**) are represented within the group data by the orange (−70 mV) and cyan (0 mV) circles in **Bb** and **Bc**) respectively. Ca, Cb. Representative current clamp traces showing a range of firing rates from a *Gad1*-GFP cIN (WT, blue trace) and a *Nkx2.1^Cre^*;Ai14;*Pcdhg^fcon3/fcon3^* (*Pcdhg* mutant, black trace) cIN responding to intracellular current injections (**Ca**), and the corresponding FI curves (**Cb**). (**Cc**) Group data from cINs recorded at 8, 9, 10, 11, and 12 DAT showing that co-transplanted *Gad1*-GFP cINs (WT, green circles) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* cINs (*Pcdhg* mutant, pink circles) have similar maximum spike rates. The current clamp traces from (**Ca** and **Cb**) are represented within the group data by the blue and black circles. (**Da**) Left: *Gad1*-GFP (WT) cIN voltage responses to repeated current injections (blue traces). Right: The membrane time constant (Tau) is calculated by fitting an exponential to the average voltage trace (black line). (**Db**) Group data from current clamp recordings of co-transplanted *Gad1*-GFP cINs (WT, green circles) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* cINs (*Pcdhg* mutant, magenta circles) at 8, 9, 10, 11, and 12 DAT shows that *Pcdhg* deletion does not affect membrane time constant. The current clamp recording from (**Da**) is represented within the group data by a black circle. (**E** and **F**) Group data from current clamp recordings of co-transplanted *Gad1*-GFP cINs (WT, green circles) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* cINs (*Pcdhg* mutant, magenta circles) at 8, 9, 10, 11, and 12 DAT shows that *Pcdhg* deletion does not affect either capacitance (**E**) or input resistance (**F**). Cells analyzed in **A--F** were taken from at least three transplant cohorts.\
Figure 13---source data 1.Analysis of the intrinsic electrophysiological properties of transplanted MGE-derived cIN precursor cells carrying WT or mutant *Pcdhg*.](elife-55374-fig13){#fig13}

###### Group data for the frequency of spontaneous excitatory and inhibitory synaptic currents (Hz), max firing rate (Hz), tau (ms), capacitance (pF), and input resistance (mOhm) from [Figure 13](#fig13){ref-type="fig"}.

The mean, standard deviation, sample size, and statistical tests are reported. Comparisons were not statistically significant following Benjamini-Hochberg multiple comparisons correction at an alpha of 0.05.

          Frequency of spontaneous excitatory synaptic currents (Hz)   Frequency of spontaneous inhibitory synaptic currents (Hz)                                                                  
  ------- ------------------------------------------------------------ ------------------------------------------------------------ -------------- ----------------------- ----------------------- --------------
          Mean ± SD                                                    Mean ± SD                                                    p value        Mean ± SD               Mean ± SD               p value
  8DAT    1.0 ± 0.7 (n = 18)                                           1.0 ± 0.7 (n = 9)                                            0.890          0.4 ± 0.2 (n = 18)      0.4 ± 0.2 (n = 6)       0.463
  9DAT    1.4 ± 1.4 (n = 19)                                           1.6 ± 1.4 (n = 21)                                           0.432          0.4 ± 0.2 (n = 15)      0.4 ± 0.2 (n = 18)      0.347
  10DAT   2.2 ± 1.0 (n = 9)                                            3.4 ± 2.8 (n = 9)                                            0.652          0.6 ± 0.2 (n = 9)       0.6 ± 0.3 (n = 7)       0.859
  11DAT   3.2 ± 2.3 (n = 14)                                           2.5 ± 1.8 (n = 13)                                           0.298          0.6 ± 0.5(n = 11)       0.7 ± 0.4 (n = 11)      0.711
  12DAT   2.6 ± 2.1 (n = 11)                                           3.3 ± 2.8 (n = 14)                                           0.597          0.7 ± 0.1 (n = 10)      0.7 ± 0.2 (n = 13)      0.436
          Max Firing Rate (Hz)                                         Tau (ms)                                                                                                                    
          *Pcdhg^fcon3/fcon3^*                                         WT                                                           Mann-Whitney   *Pcdhg^fcon3/fcon3^*    WT                      Mann-Whitney
          Mean ± SD                                                    Mean ± SD                                                    p value        Mean ± SD               Mean ± SD               p value
  8DAT    21.8 ± 23 (n = 16)                                           21.5 ± 22.9 (n = 12)                                         0.789          3.6 ± 4.3 (n = 8)       3.8 ± 2.6 (n = 4)       0.683
  9DAT    29.1 ± 25.1 (n = 17)                                         35.0 ± 22.3 (n = 19)                                         0.416          6.8 ± 5.3 (n = 5)       8.7 ± 6.7 (n = 10)      0.717
  10DAT   35.7 ± 22.8 (n = 6)                                          37.7 ± 28.6 (n = 7)                                          1.000          11.0 ± 8 (n = 6)        7.8 ± 6.7 (n = 6)       0.387
  11DAT   24.5 ± 24.4 (n = 11)                                         36.3 ± 34.9 (n = 12)                                         0.534          5.7 ± 4.3 (n = 10)      7.3 ± 5.7 (n = 9)       0.707
  12DAT   35.0 ± 32.3 (n = 10)                                         29.8 ± 29.3 (n = 12)                                         0.757          5.8 ± 4.1 (n = 8)       5.5 ± 3.9 (n = 9)       0.880
          Capacitance (pF)                                             Input Resistance (mOhm)                                                                                                     
          *Pcdhg^fcon3/fcon3^*                                         WT                                                           Mann-Whitney   *Pcdhg^fcon3/fcon3^*    WT                      Mann-Whitney
          Mean ± SD                                                    Mean ± SD                                                    p value        Mean ± SD               Mean ± SD               p value
  8DAT    18.3 ± 7.3 (n = 16)                                          11.6 ± 2.7 (n = 10)                                          0.019          257.3 ± 87.1 (n = 23)   313.6 ± 86.5 (n = 16)   0.027
  9DAT    16.4 ± 6.0 (n = 15)                                          17.2 ± 5.1 (n = 19)                                          0.465          327 ± 106.5 (n = 23)    278.9 ± 83.4 (n = 23)   0.095
  10DAT   20.5 ± 2.8 (n = 9)                                           20.2 ± 3.9 (n = 7)                                           0.837          297.5 ± 94.3 (n = 11)   264.7 ± 52.9 (n = 9)    0.304
  11DAT   22.4 ± 5.1 (n = 15)                                          20.4 ± 6.5 (n = 13)                                          0.503          269.1 ± 79.6 (n = 15)   294.2 ± 59.9 (n = 14)   0.185
  12DAT   23.2 ± 5.8 (n = 13)                                          21.5 ± 3.4 (n = 15)                                          0.338          266.5 ± 96.4 (n = 13)   262.3 ± 83.6 (n = 15)   0.882

###### Ratios are reported for the frequency of spontaneous excitatory and inhibitory synaptic currents where wild type and *Pcdhg^fcon3/fcon3^* co-transplants are compared within the same slice.

The natural log of each ratio was averaged for 8, 9, 10, 11, and 12 DAT and show that slice variation was not significant.

          Frequency of spontaneous excitatory synaptic currents      Frequency of spontaneous inhibitory synaptic currents
  ------- ------------------------------------------------------- -- -------------------------------------------------------
          LN(*Pcdhg ^fcon3/fcon3^*/WT)                               LN(*Pcdhg ^fcon3/fcon3^*/WT)
          Mean ± SD                                                  Mean ± SD
  8DAT    −0.305 ± 0.425                                             0.162 ± 0.793
  9DAT    0.177 ± 0.468                                              0.018 ± 0.550
  10DAT   0.321 ± 0.706                                              0.301 ± 0.436
  11DAT   0.120 ± 0.927                                              −0.075 ± 0.262
  12DAT   −0.523 ± 0.943                                             −0.072 ± 0.128

Discussion {#s3}
==========

The findings above indicate that *Pcdhg* genes play a critical role in regulating cIN survival during the endogenous period of cIN programmed cell death. Specifically, *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms within the *Pcdhg* cluster are essential for the selection of those cINs that survive past the period of programmed cell death and become part of the adult cortical circuit. *Pcdhg* genes do not affect the production or migration of cINs and appear to be dispensable for the survival of cINs after the period of cell death. Together with previous work in the spinal cord and retina, these results suggest that *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms are key to the regulation of programmed cell death in the CNS. In contrast, deletions of the alpha and beta *Pcdh* gene clusters did not alter cell death during this period.

Our initial approach involved the removal of *Pcdhg* function from all GAD2 expressing cells using the *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice. These mice displayed a dramatic reduction of cortical interneurons of all subtypes, including a significant decrease in the number of VIP+ cells, which are derived from the CGE. A similar observation has been recently reported by [@bib7]. In these mice, *Pcdhg* function was also removed from most other GABAergic neurons throughout the nervous system, as well as from a small fraction of astrocytes ([@bib66]). Since the removal of *Pcdhg* function in all GAD2-CRE expressing cells could affect the survival of cINs indirectly, we used *Nkx2.1^Cre^;*Ai14 ; mice to more specifically remove *Pcdhg* function from MGE derived cINs. As in the *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice, a sharp decrease in cINs was observed, but now only MGE-derived PV, SST and a subpopulation of RLN cIN were affected. The number of VIP cells was not affected in these mice, suggesting that the reduction in the number of MGE-derived cINs does not affect the survival of those derived from the CGE. Consistent with recent observations ([@bib7]), the number of un-recombined PV and SST (PV+/tdTomato- and SST+/tdTomato-) cINs in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice, increased compared to WT mice ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). These cells, which are likely derived from the dorsal NKX6.2+/NKX2.1- MGE domain ([@bib28]; [@bib29]; [@bib18]; [@bib63]) may increase their survival in compensation for the loss of Nkx2.1-derived cINs lacking *Pcdhg* function. However, we cannot exclude that the increased number of un-recombined PV and SST cells in *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* mice resulted from increased production or migration of cINs derived from regions of low, or no, expression of Nkx2.1. Further experiments will be required to understand the origin of these un-recombined PV+/Ai14- and SST+/Ai14- cINs and whether the observed increase in their numbers is due to compensatory survival mechanisms.

*Pcdhg* genes are not required for the normal production of young Nkx2.1-derived cINs in the MGE, or for their migration into the mouse cerebral cortex. The extent of proliferation in the MGE was essentially the same in *Pcdhg* WT and mutant mice, and the number of migrating MGE-derived cINs into the cortex was also indistinguishable between control and mutant mice. We did not directly address whether interference with the *Pcdha* and *Pcdhb* gene clusters affected the birth and migration of cINs, but we infer these two clusters also have no, or minimal effects on cIN production and migration because the final numbers of MGE-derived cINs were not significantly affected after the loss of either *Pcdha* or *Pcdhb*. However, the aggregate loss of *Pcdh* genes in multiple clusters might in principle be required for phenotypes to be manifested ([@bib32]). Our findings, therefore, cannot exclude the possibility that simultaneous elimination of the *Pcdha* and *Pcdhb* isoforms might have an effect on cIN production, migration, or apoptosis. However, the elimination of *Pcdhg* alone, and specifically of the *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms increases cell death among cINs, establishing that removal of a limited number of isoforms in the *Pcdhg* cluster is sufficient to reveal the cell-death phenotype.

Importantly, the increase in programmed cell death observed following the loss of *Pcdhg* function was fully rescued when the pre-apoptotic gene *Bax* was also eliminated. Not only was the increased *Pcdhg*-dependent cell death eliminated in *Bax* mutant animals, but these animals had \~40% increase in the numbers of surviving cINs compared to WT controls, identical to the effect of the *Bax* mutation in wild type animals. This observation is consistent with previous observation showing that \~ 40% of cINs are eliminated during the period of programmed cell death ([@bib64]; [@bib71]). Moreover, the increased death of cINs after removal of *Pcdhg* function occurs precisely during the normal period of programmed cell death. These observations indicate that *Pcdhg* isoforms are required specifically to regulate cIN numbers during the critical window of programmed cell death. This is consistent with previous studies in the retina and spinal cord that have pointed to *Pcdhg*, and specifically the C-isoforms (*Pcdhgc3, Pcdhgc4 and Pcdhgc5)*, as key mediators of programmed cell death ([@bib40]; [@bib10]). Interestingly, in all three neural structures, the cortex, the spinal cord, and the retina, *Pcdhg* C-isoforms appear to be the key regulators of survival of local circuit interneurons.

A recent study suggests that the *Pcdhgc4* isoform is the key mediator in the regulation of neuronal cell death in the spinal cord ([@bib21]). How the specific *Pcdhgc4* isoform in the *Pcdhg* gene cluster mediates cell death remains a fundamental question for future research. Interestingly, the *Pcdhgc4* isoform appears to be unique in that it is the only *Pcdh* isoform that does not bind in a homophilic manner ([@bib21]) and it is not translocated to the membrane unless it is associated with other *Pcdha* or *Pcdhg* ([@bib3]). The mechanism by which the *Pcdhgc4* isoform regulates cell-cell interactions among young cINs, leading to the adjustment of local circuit neuron numbers, remains unclear.

Heterochronic transplantation of cIN from the MGE into the cortex of WT mice allowed us to test for the survival of *Pcdhg* WT and *Pcdhg* mutant cIN simultaneously and in the same environment. As previously reported ([@bib64]), cINs die following their own time-course of maturation. Consistent with this, the transplanted cells (extracted from the MGE at E13.5) died with a delay of 6--12 days compared to the endogenous host cINs when transplanted into P0-P6 WT mice. This is consistent with the notion that the cellular age of cIN determines the timing of programmed cell death ([@bib64]). Interestingly, the role of *Pcdhg* function was clearly evident in these co-transplants in that the survival of the mutant cells was extremely low compared to that of WT cells. The dramatic decrease in the survival of *Pcdhg* mutant cINs occurs precisely during the period of programmed cell death for the transplanted population. The survival of transplanted WT cINs as well as that of *Pcdhg* mutant cINs was constant over a wide range of densities, as evidenced by the fact that while the density of transplanted cINs decreases as a function of the distance from the transplantation site, the proportion of dying cells of both phenotypes was similar at different distances from the site of transplantation.

Interestingly, the survival of WT cIN may also be reduced when co-transplanted with *Pcdhg* deficient MGE-cells although this difference did not reach statistical significance with the numbers of cases studied. If true, these findings would be consistent with the notion that cell-cell interactions among young cIN after their migration is an essential step in determining their final numbers. However, we cannot exclude that the increase in the elimination of WT cells may result from a non-specific (e.g., toxic) effect of the increased cell death among *Pcdhg* mutant cells. If the latter occurs, the process is specific to the population of Nkx2.1^+^ MGE-derived cINs because there was no effect on cell death of WT CGE-derived VIP cINs ([Figure 3E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) or on non-Nkx2.1-derived SST or PV cells ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). Interactions mediated by Pcdhg, and specifically among the C-isoforms, may directly or indirectly regulate survival of cINs of the same age and origin.

Unlike the spinal cord where cell death takes place prenatally ([@bib69]; [@bib53]), cIN programmed cell death occurs mostly postnatally. Since mice lacking *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms die soon after birth, we could not study normal cIN cell death directly in these mutant animals. We, therefore, took advantage of transplantation and co-transplantation to compare the survival of cells lacking these three isoforms. The loss of cINs lacking *Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* isoforms was identical to that when the function of the entire *Pcdhg* cluster is lost. This further suggests that these *Pcdhg* C-isoforms (*Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5*) are the key to the regulation of cIN death. The co-transplantation assay, implemented in the present study, provides strong evidence that *Pcdhg* in cINs are key to their selection by programmed cell death. *Pcdhg* could be mediating initial cell-cell interactions that are important for the survival of cINs. Two non-exclusive possibilities exist: (1) *Pcdhg* mediate cell-cell interaction among young cINs to adjust their population size, and levels of inhibition, according to the numbers that reached the cortex; (2) *Pcdhg* mediate interactions with locally produced excitatory pyramidal neurons to adjust final numbers according to local levels of excitation. For the latter, MGE-derived cIN could interact with pyramidal neurons via *Pcdhg* C-isoforms. However, alternative \# 2 is unlikely to explain how *Pcdhg* adjust cIN numbers since using conditional removal of *Pcdhg* in pyramidal cells shows no effect on the survival of cINs ([@bib7]). However, we cannot exclude that initial connectivity with excitatory pyramidal neurons may indeed require the proper expression of *Pcdhg* among cINs through non-homophilic interactions.

A recent study has shown that coordinated activity of synaptically connected assemblies of cINs is essential for their survival ([@bib13]). Pyramidal cells receive information from these assemblies via GABA~A~γ2-signaling and through the de-synchronization of their activity regulate cIN programmed cell death. *Pcdhg* could be important in bringing together cINs of a common origin and at similar stages of maturation for the formation of initial cIN functional assemblies. The formation of these assemblies of synchronously firing cINs and the subsequent selection by pyramidal driven de-synchronization could explain both cell/population autonomous ([@bib64]), and non-cell autonomous ([@bib71]) mechanisms of cIN programmed cell death. Interestingly, PCDHGC5 binds to the GABA~A~γ subunit of the GABA receptor ([@bib42]), but the role of PCDHGC5-GABA~A~γ interaction on neuronal survival remains unknown. The transplantation assay provides a powerful tool to further study how *Pcdhg*, cell-cell interactions, and cellular age contribute to cIN selection. It will be interesting, for example, to determine if heterochronically transplanted cINs form functional assemblies and whether these assemblies are affected by the removal of different *Pcdhg* isoforms.

During the evolution of multiple mammalian species including that of humans, the cerebral cortex has greatly expanded in size and in the number of excitatory and inhibitory neurons it contains. Interestingly, the proportion of cINs to excitatory pyramidal neurons has remained relatively constant. Appropriate numbers of inhibitory cINs are considered essential in the modulation of cortical function. The embryonic origin of cINs, far from the cerebral cortex, raises basic questions about how their numbers are ultimately controlled in development and during evolution. Coordinated increased production of inhibitory interneurons in the MGE and CGE is an essential step to satisfy the demand of an expanded cortex ([@bib22]). In addition, MGE and CGE derived interneurons in larger brains require longer and more protracted migratory periods ([@bib52]). Interneurons arrive in excess of their final number. This is ultimately adjusted by a period of programmed cell death once the young cINs have arrived in the cortex. Here we have identified the C-isoforms (*Pcdhgc3, Pcdhgc4 and Pcdhgc5)* in the *Pcdhg* cluster as an essential molecular component that regulates programmed cell death among cINs. The fact that a cell surface adhesion protein plays a key role in this regulation suggests that interactions with other cells, possibly other cINs of the same age ([@bib64]), or possibly excitatory pyramidal cells ([@bib71]), is part of the logic to adjust the final number of these essential GABAergic cells for proper brain function. An understanding of the cell-cell interactions that use *Pcdhg* C-isoform to regulate cIN cell death should give fundamental insights into how the cerebral cortex forms and evolves.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\               Designation                                                                                          Source or\                                                   Identifiers                                                                       Additional\
  (species) or\                                                                                                                    reference                                                                                                                                      information
  resource                                                                                                                                                                                                                                                                        
  --------------------------- ---------------------------------------------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------
  Genetic reagent (*mouse*)   *Gad2^Cre^*                                                                                          PMID:[21943598](https://pubmed.ncbi.nlm.nih.gov/21943598/)                                                                                     Also referred to as *Gad2*-IRES-Cre knock-in

  Genetic reagent (*mouse*)   *Nkx2.1^Cre^*                                                                                        PMID:[17990269](https://pubmed.ncbi.nlm.nih.gov/17990269/)                                                                                     Also referred to as C57BL/6J-Tg(*Nkx2-1*-cre)2Sand/J

  Genetic reagent (*mouse*)   *PV^Cre^*                                                                                            PMID:[15836427](https://pubmed.ncbi.nlm.nih.gov/15836427/)                                                                                     Also referred to as B6;129P2-*Pvalbtm1*(*cre*)*Arbr*/J

  Genetic reagent (*mouse*)   *Sst^Cre^*                                                                                           PMID:[21943598](https://pubmed.ncbi.nlm.nih.gov/21943598/)                                                                                     Also referred to as *Ssttm2.1*(*cre*)*Zjh*/J

  Genetic reagent (*mouse*)   Ai14                                                                                                 The Jackson Laboratory                                                                                                                         Also referred to as Ai14 , Ai14 *D or* Ai14 (*RCL-tdT*)*-D*

  Genetic reagent (*mouse*)   *Gad1*-GFP                                                                                           The Jackson Laboratory                                                                                                                         Also referred to as *G42* line.

  Genetic reagent (*mouse*)   *Bax^-/-^*                                                                                           The Jackson Laboratory                                                                                                                         Also referred to as B6;129-Baxtm2Sjk Bak1tm1Thsn/J

  Genetic reagent (*mouse*)   *Pcdha^acon/acon^*                                                                                   PMID:[28450636](https://pubmed.ncbi.nlm.nih.gov/28450636/)                                                                                     Referred to as *Pcdhα^f/f^* and *Pcdhα^-/-^* in original publication.

  Genetic reagent (*mouse*)   *Pcdhb^del/del^*                                                                                     PMID:[28450637](https://pubmed.ncbi.nlm.nih.gov/28450637/)                                                                                     Referred to as *Pcdhß*^-/-^ in original publication.

  Genetic reagent (*mouse*)   *Pcdhg^tako/tako^; Pcdhga1, Pcdhga2, and Pcdhga3* mutant; *Pcdhga1, Pcdhga2, and Pcdhga3* KO         PMID:[22884324](https://pubmed.ncbi.nlm.nih.gov/22884324/)                                                                                     Referred to as *Pcdhg^tako/tako^* in original publication.

  Genetic reagent (*mouse*)   *Pcdhg^tcko/tcko^; Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5 mutant; Pcdhgc3*, *Pcdhgc4*, and *Pcdhgc5* KO   PMID:[22884324](https://pubmed.ncbi.nlm.nih.gov/22884324/)                                                                                     Referred to as *Pcdhg^tcko/tcko^* in original publication.

  Genetic reagent (*mouse*)   *Pcdhg^fcon3/fcon3^*                                                                                 PMID:[19029044](https://pubmed.ncbi.nlm.nih.gov/19029044/)                                                                                     Referred to as *Pcdh-γ^fcon3^* in original publication.

  Antibody                    anti-GFP (chicken polyclonal)                                                                        Aves Lab                                                     Cat\# GFP-1020, RRID:[AB_10000240](https://scicrunch.org/resolver/AB_10000240)    IF(1:2500)

  Antibody                    Anti-Reelin (mouse monoclonal)                                                                       MBL International                                            Cat\#: MBL, D223--3, RRID:[AB_843523](https://scicrunch.org/resolver/AB_843523)   IF(1:500)

  Antibody                    Anti-PV (rabbit antiserum)                                                                           Swant                                                        Cat\#: PV27 , RRID:[AB_2631173](https://scicrunch.org/resolver/AB_2631173)        IF(1:1000)

  Antibody                    Anti-PV (mouse monoclonal)                                                                           Sigma-Aldrich                                                Cat\#: P3088, RRID:[AB_477329](https://scicrunch.org/resolver/AB_477329)          IF(1:500)

  Antibody                    Anti-SST (rat, polyclonal                                                                            Santa Cruz Biotechnology                                     Cat\#:sc-7819, RRID:[AB_2302603](https://scicrunch.org/resolver/AB_2302603)       IF(1:500)

  Antibody                    Anti-cleaved caspase 3 (rabbit polyclonal)                                                           Cell Signaling Technology                                    Cat\#: 9661L, RRID:[AB_2341188](https://scicrunch.org/resolver/AB_2341188)        IF(1:400)

  Antibody                    Anti-phosphohiston-H3 (rabbit polyclonal)                                                            EDM Millipore                                                Cat\#: 06--570, RRID:[AB_310177](https://scicrunch.org/resolver/AB_310177)        IF(1:500)

  Antibody                    Anti-NKX2-1 (rabbit polyclonal)                                                                      Life Technologies                                            Cat\#: sc-13040, ARRID:[AB_793532](https://scicrunch.org/resolver/AB_793532)      IF(1:250)

  Chemical compound, drug     DNAse I                                                                                              Sigma Millipore                                              Cat\#: 260913-10MU                                                                180 ug/mL

  Commercial assay or kit     QuantiTect Rev. Transcription Kit                                                                    Qiagen                                                       Cat\#: 205311                                                                     

  Software, algorithm         Stereo Investigator                                                                                  MBF bioscience                                                                                                                                 

  Software, algorithm         Neurolucida                                                                                          MBF bioscience                                                                                                                                 

  Software, algorithm         custom software written in MATLAB                                                                    'other'                                                                                                                                        [@bib39]. mPhys. MATLAB Central File Exchange. (<https://www.mathworks.com/matlabcentral/fileexchange/21903-mphys>). 1.2.0.0.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

 R26-Ai14 , *Gad1*-GFP, *Gad2*-ires-Cre (*Gad2^Cre^*), BAC-*Nkx2.1*-Cre (*Nkx2.1^Cre^*), *Sst*-ires-Cre (*Sst^Cre^*), PV-IRES-Cre-pA (*PV^Cre^*), *Bax^-/-^*, *Bax^fl/fl^* and WT C57BL/6J breeders were purchased from the Jackson Laboratory. Whenever possible, the number of males and females was matched for each experimental condition. All protocols and procedures followed the University of California, San Francisco (UCSF) guidelines and were approved by the UCSF Institutional Animal Care Committee.

*Pcdhg* loss of function mice were obtained by crossing *Pcdhg^fcon3/fcon3^* mice with *Gad2^Cre^;*Ai14*;Pcdhg^fcon3/+^* mice, *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/+^, PV^Cre^;*Ai14*;Pcdhg^fcon3/+^* or *Sst^Cre^;*Ai14*;Pcdhg^fcon3/+^. Pcdhga1, Pcdhga2 and Pcdhga3* isoform knockout mice were obtained from crosses of *Pcdhg^tako/tako^* mice to *Nkx2.1^Cre^;*Ai14*;Pcdhg^tako/+^* mice.

*Pcdha* loss function mice were obtained by crossing *Pcdha^acon/acon^* mice with *Nkx2.1^Cre^;*Ai14*; Pcdha^acon/+^* mice. *Pcdhb* loss function mice were obtained by crossing *Pcdhb^del/del^* mice with *Nkx2.1^Cre^;*Ai14*;Pcdhb^del/+^* mice. Embryonic donor tissue was produced by crossing WT C57BL/6J to heterozygous mice expressing green fluorescent protein-expressing (GFP) driven by *Gad1 promoter. Pcdhg^fcon3/fcon3^* (tdTomato-expressing) tissue was obtained from embryos produced by crossing *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/+^* mice with *Pcdhg^fcon3/fcon3^* mice. *Pcdhg^tako^*^/*tako*^ (tdTomato-expressing) tissue was obtained from embryos produced by crossing *Nkx2.1^Cre^;*Ai14*;Pcdhg^tako/+^* mice to homozygote *Pcdhg^tako/tako^* mice. *Pcdhg^tcko/tcko^* (tdTomato-expressing) tissue was obtained from embryos produced by crossing *Nkx2.1^Cre^;*Ai14*;Pcdhg^tcko/+^* mice to heterozygote *Pcdhg^tcko^*^/+^ mice. Homozygous *Pcdhg^tcko^*^/*tcko*^ mice die around birth. *GAD1*-GFP and *Nkx2.1^Cre^;* Ai14 offspring were genotyped under an epifluorescence microscope (Leica), and PCR genotyping was used to screen for *Pcdhg^fcon3/fcon3^, Pcdhg^tako/tako^ and Pcdhg^tcko/tcko^* embryos in GFP or Ai14 positive animals. All cell transplantation experiments were performed using wild type C57Bl/6 recipient mice. All mice were housed under identical conditions.

Immunostaining {#s4-2}
--------------

Mice were fixed by transcardiac perfusion with 10 mL of ice-cold PBS followed by 10 mL of 4% formaldehyde/PBS solution. Brains were incubated overnight (12--24 hr) for postfixation at 4°C, then rinsed with PBS and cryoprotected in 30% sucrose/PBS solution for 48 hr at 4°C. Unless otherwise stated, immunohistochemistry was performed on 50 μm floating sections in Tris Buffered Saline (TBS) solution containing 10% normal donkey serum, 0.5% Triton X-100 for all procedures on postnatal mice. Immunohistochemistry from embryonic tissue was performed on 20 μm cryostat sections. All washing steps were done in 0.1% Triton X-100 TBS for all procedures. Sections were incubated overnight at 4°C with selected antibodies, followed by incubation at 4°C overnight in donkey secondary antibodies (Jackson ImmunoResearch Laboratories). For cell counting and *post hoc* examination of marker expression, sections were stained using chicken anti-GFP (1:2500, Aves Labs, GFP-1020, RRID:[AB_10000240](https://scicrunch.org/resolver/AB_10000240)), mouse anti-Reelin (1:500 MBL, D223--3, RRID:[AB_843523](https://scicrunch.org/resolver/AB_843523)), rabbit anti-PV (1:1000, Swant PV27 , RRID:[AB_2631173](https://scicrunch.org/resolver/AB_2631173)), mouse anti-parvalbumin (anti-PV, 1:500, Sigma-Aldrich, P3088, RRID:[AB_477329](https://scicrunch.org/resolver/AB_477329)), rat anti-somatostatin (SST, 1:500, Santa Cruz Biotechnology, sc-7819, RRID:[AB_2302603](https://scicrunch.org/resolver/AB_2302603)), anti-cleaved caspase 3 (1:400, Cell Signaling Technology, 9661L, RRID:[AB_2341188](https://scicrunch.org/resolver/AB_2341188)), rabbit anti-phosphohistone-H3 (1:500; EDM Millipore, RRID:[AB_310177](https://scicrunch.org/resolver/AB_310177)), rabbit anti-NKX2-1 (1:250, Life Technologies, RRID:[AB_793532](https://scicrunch.org/resolver/AB_793532)).

Cell counting {#s4-3}
-------------

For cell density counts in the visual and barrel cortex ([Figure 2C & C'](#fig2){ref-type="fig"}, [Figure 3C & C'](#fig3){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}), cells were directly counted using a Zeiss Axiover-200 inverted microscope (Zeiss) and an AxioCam MRm camera (Zeiss), using Stereo Investigator (MBF). tdTomato+ cells were counted in every six sections (i.e., 300 µm apart) along the rostral-caudal axis of visual and barrel cortex. Total cell counts were extrapolated by Stereo Investigator. Cell densities were determined by dividing the total number of tdTomato+ cells by the volume of the region of interest in the visual or barrel cortex, identified by landmarks, for each animal. To measure PV, SST, RLN and VIP-positive cell densities in the visual cortex ([Figure 2D](#fig2){ref-type="fig"} and [Figure 3E](#fig3){ref-type="fig"}), cells were counted from confocal-acquired images. Cleaved caspase-3-positive (CC3+) cells were counted from images acquired on a Zeiss Axiover-200 inverted microscope (Zeiss) and an AxioCam MRm camera (Zeiss) using Neurolucida (MBF). Cleaved caspase-3-positive cells were counted in the cortex of every six sections along the rostral-caudal axis for each animal (Figure A and B). Cells in the olfactory bulb, hippocampus, and piriform cortex were not counted. For layer distribution analysis of tdTomato+ cells and for analysis of tdTomato negative (non-recombined) PV and SST positive cells ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Figure 3---figure supplements 3](#fig3s3){ref-type="fig"} and [4](#fig3s4){ref-type="fig"}, cells were counted from confocal-acquired images and using Fiji software cell counter function.

Cell dissection and transplantation {#s4-4}
-----------------------------------

Unless otherwise mentioned, MGEs were dissected from E13.5 embryos as previously described ([@bib64]). The day when the sperm plug was observed was considered E0.5. Dissections were performed in ice-cold Leibovitz L-15 medium. MGEs were kept in L-15 medium at 4°C. MGEs were mechanically dissociated into a single cell suspension by repeated pipetting in L-15 medium containing DNAse I (180 ug/ml). The dissociated cells were then concentrated by centrifugation (4 min, 800xg). For all co-transplantations, the number of cells in each suspension (GFP+ or tdTomato+) was determined using a hemocytometer. Concentrated cell suspensions were loaded into beveled glass micropipettes (≈70--90 μm diameter, Wiretrol 5 μl, Drummond Scientific Company) prefilled with mineral oil and mounted on a microinjector. Recipient mice (C57Bl/6) were anesthetized by hypothermia (\~4 min) and positioned in a clay head mold that stabilizes the skull ([@bib45]). Micropipettes were positioned at an angle of 0 degrees from vertical in a stereotactic injection apparatus. Unless otherwise stated, injections were performed in the left hemisphere 1 mm lateral and 1.5 mm anterior from Lambda, and at a depth of 0.8 mm from the surface of the skin. After the injections were completed, transplant recipients were placed on a warm surface to recover from hypothermia. The mice were then returned to their mothers until they were perfused or weaned (P21). Transplantation of *Nkx2.1^Cre^;*Ai14*;Pcdhg^tako/tako^* was performed using frozen cells ([Figure 11B](#fig11){ref-type="fig"}). For these experiments, dissected MGEs from each embryo were collected in 500 uL L15 and kept on ice until cryopreserved. MGEs were resuspended in 10% DMSO in L15 and cryopreserved as previously described ([@bib57]). Vials were cooled to −80°C at a rate of −1 °C/minute in a Nalgene Mr. Frosty Freezing Container and then transferred to liquid nitrogen for long term storage. Prior to transplantation, vials were removed from −80°C and thawed at 37°C for 5 min, after which the freezing medium was removed from the vial and replaced with 37 °C L-15. Dissociation was performed as above.

For cell counts from transplanted animals, *Gad1*-GFP positive cells and tdTomato-positive cells were counted in all layers of the neocortex. Cells that did not display neuronal morphology were excluded from all quantifications. The vast majority of cells transplanted from the E13.5 MGE exhibited neuronal morphologies in the recipient brain. GFP and tdTomato-positive cells were counted from tiles acquired on a Zeiss Axiover-200 inverted microscope (Zeiss) with an AxioCam MRm camera (Zeiss); using Neurolucida (MBF). For quantification of the absolute numbers of transplanted cells in the neocortex of host recipients, cells from every second coronal section were counted ([Figure 9](#fig9){ref-type="fig"}). The raw cell counts were then multiplied by the inverse of the section sampling frequency (2) to obtain an estimate of total cell number ([Figure 10](#fig10){ref-type="fig"}). In some experiments the absolute number of grafted cells varies between transplants; hence we report findings as the fraction of cells (GFP or tdTomato) that survive from the total transplant-derived cell number in that animal (GFP + tdTomato-positive) ([Figure 8](#fig8){ref-type="fig"}). We determined for these experiments the number of transplant-derived cells of the different genotypes before and, in different animals, after the period of cell death. For some experiments, we also quantified the number of transplant-derived cells during the period of cell death ([Figure 12B](#fig12){ref-type="fig"}). In data presented as the fraction of transplant-derived cells ([Figure 8](#fig8){ref-type="fig"} and [Figure 11](#fig11){ref-type="fig"}), GFP positive and tdTomato-positive cells were counted from coronal sections along the rostral-caudal axis in at least 10 sections per animal. The number of GFP or tdTomato-positive cells was divided by the total cell number (GFP + tdTomato) in that section. This fraction does not reflect the absolute number of cells, but their relative contribution to the overall population of transplant-derived cells at different DAT. For one experiment ([Figure 10](#fig10){ref-type="fig"}), we calculated the absolute number of transplant-derived WT (GFP) and *Pcdhg^fcon3/fcon3^* (tdTomato) cells. For this experiment, 50 K cells of each genotype were counted before transplantation.

Neuron Morphology analysis {#s4-5}
--------------------------

Recipient brains were co-transplanted with *Gad1*-GFP (WT *Pcdhg*) and *Nkx2.1^Cre^;*Ai14*;Pcdhg^fcon3/fcon3^* (mutant *Pcdhg*) MGE cIN precursors. Transplanted cells were identified in sections (50 µm) stained for GFP and tdTomato and analyzed at 6, 8, 10 and 12 days after transplantation (DAT). Neuron morphology was reconstructed from confocal image (20X objective-4X zoom) stacks taken at 1 μm intervals, using Neurolucida software (MBF). Sections with a relatively low density of GFP+ (WT) and TdTomato+ (Mutant) transplant-derived neurons (in order to clearly image individual cells) were selected and (145.31 um^2^) fields tiled to cover all the visible processes. All GFP+ (WT) and TdTomato+ (Mutant) positive neurons in these tiles were reconstructed. Neuron morphometric analysis was done using Neurolucida Explorer.

RT-PCR {#s4-6}
------

Total RNA was prepared from dissected cortex of using Trizol (Invitrogen) and reverse-transcribed by Quantiscript Reverse Transcriptase (Qiagen), using a mix of oligo-dT and random primers, according to the manufacturer\'s protocol. Primer sequences for gene expression analysis in [Figure 1](#fig1){ref-type="fig"} are provided in [Appendix 1---table 1](#app1table1){ref-type="table"}. 

Slice electrophysiology {#s4-7}
-----------------------

As in [@bib37]; [@bib38]; [@bib55], host animals were anesthetized and decapitated at 8, 9, 10, 11, or 12 days after transplant. The brain was removed into ice-cold dissection buffer containing (in mM): 234 sucrose, 2.5 KCl, 10 MgSO~4~, 1.25 NaH~2~PO~4~, 24 NaHCO~3~, 11 dextrose, 0.5 CaCl~2~, bubbled with 95% O~2~/5% CO~2~ to a pH of 7.4. Coronal slices of visual cortex (200 µm thick) were cut via vibratome (Precisionary Instruments) and transferred to artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 3 KCl, 2 MgSO~4~, 1.23 NaH~2~PO~4~, 26 NaHCO~3~, 10 dextrose, 2 CaCl~2~ (bubbled with 95% O~2~/5% CO~2~), incubated at 33°C for 30 min, then stored at room temperature. Fluorescently identified transplant-derived MGE-lineage interneurons (tdTomato+; *Pcdhg^fcon3/fcon3^* or GFP; WT) were viewed using IR-DIC video microscopy. Whole-cell current-clamp recordings were made with a Multiclamp 700B (Molecular Devices) using an internal solution that contained (in mM): 140 K-gluconate, 2 MgCl~2~, 10 HEPES, 0.2 EGTA, 4 MgATP, 0.3 NaGTP, 10 phosphocreatine (pH 7.3, 290 mosm). Data were low-pass filtered at 2.6 kHz and digitized at 10 kHz by a 16 bit analog-to-digital converter (National Instruments). Data acquisition and analysis were done with custom software written in Matlab (<https://www.mathworks.com/matlabcentral/fileexchange/21903-mphys>). A Mann-Whitney (nonparametric) test, followed by multiple comparisons correction using the Benjamini-Hochberg stepdown method for control of false discovery rate (0.05 familywise) was used for the determination of statistical significance for all comparisons of physiological properties.

Statistical Analysis {#s4-8}
--------------------

The person carrying quantifications was blinded to the genotype, except for data shown in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, and [Figure 3---figure supplements 3](#fig3s3){ref-type="fig"} and [4](#fig3s4){ref-type="fig"}. With the exception of slice electrophysiology data, all results were plotted and tested for statistical significance using Prism 8. All samples were tested for normality using the Shapiro-Wilk normality test. Unpaired comparisons were analyzed using the two-tailed unpaired Student's *t* test for normally distributed, and Mann-Whitney test for not normally distributed samples. For multiple comparisons analysis of one variable, either a one-way ANOVA with post hoc Tukey's test was used to compare the mean of each column with the mean of every other column, or a Dunnett test was used to compare the mean of each column to the mean of the control group for normally distributed samples. For samples with non-Gaussian distributions, a nonparametric Kruskal-Wallis test was performed followed by a post-hoc Dunn's test. Two-way ANOVA with post hoc Sidak's test was used for multiple comparisons with more than one variable. Outliers were identified using ROUT method with alpha set to 0.05.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000002National Institutes of Health R01NS028478 to Arturo Alvarez-Buylla.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health EY02517 to Arturo Alvarez-Buylla.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health R01DC014101 to Andrea R Hasenstaub.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health R01EY025174 to Michael P Stryker.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health 5F32EY029935 to Benjamin Rakela, Michael P Stryker.

-   John G. Bowes Research Fund to Arturo Alvarez-Buylla.

-   The Klingenstein Foundation to Andrea R Hasenstaub.

-   Coleman Memorial Fund to Andrea R Hasenstaub.

-   Hearing Research institute to Andrea R Hasenstaub.

We thank Joshua Sanes for kindly proving the *Pcdhg^fcon3^* mice. We also thank Ricardo Romero, Jose Rodrigues, and Cristina Guinto for technical help and John Rubenstein, Arnold Kriegstein, and Duan Xin for the insightful discussion of experimental data. This work was supported by NIH Grants (R01 NS028478, R01 EY02517) and a generous gift from the John G Bowes Research Fund to AAB; NIH Grant R01DC014101 to ARH, the Klingenstein Foundation to ARH, Hearing Research Inc to ARH, and the Coleman Memorial Fund to ARH; NIH Grants R01EY025174 and 5F32EY029935 to MPS and 5F32EY029935 to BR. AAB is the Heather and Melanie Muss Endowed Chair and Professor of Neurological Surgery at UCSF. MPS is a recipient of the Research to Prevent Blindness Disney Award for Amblyopia Research.

Additional information {#s5}
======================

No competing interests declared.

is cofounder, serves on the scientific advisory board, and owns shares in Neurona Therapeutics.

Conceptualization, Formal analysis, Investigation, Writing - original draft, Writing - review and editing.

Conceptualization, Investigation.

Formal analysis, Investigation, Visualization, Writing - review and editing.

Data collection.

Data collection.

Conceptualization, Resources.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Project administration, Writing - review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Project administration, Writing - review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing.

Animal experimentation: Data presented in this study were acquired following the University of California, San Francisco (UCSF) Institutional Animal Care Committee guidelines under the following protocols: AN178775-02C, AN180588, AN175872.

Additional files {#s6}
================

Data availability {#s7}
=================

Data generated for this study are included in the manuscript and source data files have been provided for Figures 1 to 13.

###### Clustered protocadherin primer sequences for RT-PCR gene expression analysis in [Figure 1](#fig1){ref-type="fig"}.

  Gene name    Oligo name       Sequence                    forward/reverse
  ------------ ---------------- --------------------------- -----------------
  *Pcdhga1*    *Pcdhg*a1        CACGAGAGCTGTGAGAAACAGG      F
  *Pcdhga2*    *Pcdhg*a2        CTGATTTCCTCTCAGCACCTCAG     F
  *Pcdhga3*    *Pcdhg*a3        GAAACGAAAGAAGACCCCACGC      F
  *Pcdhga4*    *Pcdhg*a4        CTCCTGGTATCTCAAGACTTGC      F
  *Pcdhga5*    *Pcdhg*a5        CACACAAAGAAGAGCCCGGAGA      F
  *Pcdhga6*    *Pcdhg*a6        GCAAAGAGGAAGACTCTCTTGA      F
  *Pcdhga7*    *Pcdhg*a7        TCAAGAATGTAAGGGTGAAGCC      F
  *Pcdhga8*    *Pcdhg*a8        CATCCATAGATTTCCATGAGAATAA   F
  *Pcdhga9*    *Pcdhg*a9        TCAGTTGAGCCCAAGTTTCCT       F
  *Pcdhga10*   *Pcdhg*a10       CCAAGTGTCCTGTAGAAGACGC      F
  *Pcdhga11*   *Pcdhg*a11       GCGAGCCTCTCCTGATAACTG       F
  *Pcdhga12*   *Pcdhg*a12       CTTTTACCATCGGGTGATTCGG      F
  *Pcdhgb1*    *Pcdhg*b1        CAGGATCTCCTGTGCGATGATC      F
  *Pcdhgb2*    *Pcdhg*b2        GACTCTTGGGTACCAGGTACTC      F
  *Pcdhgb4*    *Pcdhg*b4        TGATCAGTTGAAATCAGGACAAGA    F
  *Pcdhgb5*    *Pcdhg*b5        CCTTCTTTGCCCTGAGTCATC       F
  *Pcdhgb6*    *Pcdhg*b6        CTTAATTCCGCTTCACCTTGG       F
  *Pcdhgb7*    *Pcdhg*b7        AAAGATAGCTCCTCGGCACTG       F
  *Pcdhgb8*    *Pcdhg*b8        CGAGACCTTTGTACGGAAGC        F
  *Pcdhgc3*    *Pcdhg*c3        GCTGCGAAGTTGTGATCCTGTG      F
  *Pcdhgc4*    *Pcdhg*c4        CAAGCTGTCCACCCTCTGATCTT     F
  *Pcdhgc5*    *Pcdhg*c5        GCCTTGCGTTCCCGCTCTAGTA      F
  *PcdhgCon*   *Pcdhg*Con       GTAAACTGGGGTCCGTATCGAG      R
  *Pcdhga1*    *Pcdhg*A_1       TTTTGTCAGCACCCCAGTC         F
  *Pcdhga2*    *Pcdhg*A_2       TTTCCTCTCAGCACCTCAGTC       F
  *Pcdhga3*    *Pcdhg*A_3       GTGGGAAAAGCGAGCCTCTTA       F
  *Pcdhga4*    *Pcdhg*A_4       AGCTGTGGGAAGAGTGATCC        F
  *Pcdhga5*    *Pcdhg*A_5       AGAGCTGTGAGAAGAGTGAGC       F
  *Pcdhga6*    Pcdh_γA6         CATCAGTCAGGAGGGCTGTG        F
  *Pcdhga7*    *Pcdhg*A_7       ATCAGCCAAGATAGCTGTGAG       F
  *Pcdhga8*    2 *Pcdhg*A_8     CATCCATAGATTTCCATGAG        F
  *Pcdhga9*    2Pcdh_γA9        TGTGGGAAGAGTGAACCTCTG       F
  *Pcdhga11*   3Pcdh_γA11       GAAAAGCGAGCCTCTCCTG         F
  *Pcdhgb1*    *Pcdhg*B_1       TGTGCGATGATCCTTCTGTG        F
  *Pcdhgb2*    3Pcdh_γB2        GACTCCGGAAGTTGCTCCTC        F
  *Pcdhgb4*    2Pcdh_γB4        CAGGACAAGATCTACAATTTGC      F
  *Pcdhgb5*    4- *Pcdhg*B5     TCTGGACAAGGCCTTCTTTG        F
  *Pcdhgb6*    Pcdh_γB6         GATCGTTTCCGGTAGTTCTCC       F
  *Pcdhgb7*    2- *Pcdhg*B7     TCCAGCCGCACAAGATATTC        F
  *Pcdhgb8*    2- *Pcdhg*B8     CGAGACCTTTGTACGGAAGC        F
  *Pcdhgc3*    *Pcdhg*C_3       TGCGAAGTTGTGATCCTGTG        F
  *Pcdhgc4*    *Pcdhg*C_4       CAAGCTGTCCACCCTCTGATC       F
  *PcdhgCon*   *Pcdhg*\_COM-R   GAGAGAAACGCCAGTCAGTG        R
  *Pcdha1*     2-PcdhAlpha_1    AAAGAAGTGACCACGCAGAAG       F
  *Pcdha2*     PcdhA2-F         GGAATCAGCAGAAGAGAGACAA      F
  *Pcdha3*     PcdhAlpha_3      ACACCATGCCCAGTTAATCAAG      F
  *Pcdha4*     PcdhAlpha_4      TCTGATTCAAGGGACAGAGAGG      F
  *Pcdha5*     Pcdh_α5          TTCAGTCCCAGCCTACCTCA        F
  *Pcdha6*     Pcdh_α6          TGAGCATCAGGATTTGAACG        F
  *Pcdha7*     Pcdh_α7          GGGTCCCAGCTCTACAGATAAC      F
  *Pcdha8*     Pcdh_α8          TTCTTTGGACTCCTCCGAGA        F
  *Pcdha9*     PcdhAlpha_9      CCGAAGTGGGAATGGAAAGT        F
  *Pcdha10*    PcdhAlpha_10     CAGTGTTCCTCCTGGTTTGG        F
  *Pcdha11*    Pcdh_α11         TCCCAACCTGGGTAGAGATG        F
  *Pcdha12*    PcdhAlpha_12     TGCAGAGGACACATGTCAGAG       F
  *Pcdhac1*    PcdhAlpha_C1     TGCCAGTATCCTGTGTTCAGA       F
  *Pcdhac2*    Pcdh_αc2         AACTCACCGGCCAAAGTAGG        F
  *PcdhaCon*   Pcdh_α-CR        TGCTCTTAGCGAGGCAGAGTAG      R
  *Pcdhb1*     pcdhb1_F         TAGTTGCCGAGGGTAACAGG        F
  *Pcdhb1*     Pcdh_ß1_R        GGGTCAGATTTGCCACAAAG        R
  *Pcdhb2*     2Pcdh_ß2_F       AATGGTTTGCTCCATCCAAG        F
  *Pcdhb2*     2Pcdh_ß2_R       GATCCAGGGCTGTGTTTGTC        R
  *Pcdhb3*     PcdhB3-F         TCAGGGAAATGCACAGTCATAG      F
  *Pcdhb3*     PcdhB3-R         CACAGTTTCTGCTGAATTCTCG      R
  *Pcdhb4*     pcdhb4_F         TCTGGGATGACCACAGTTCA        F
  *Pcdhb4*     pcdhb4_R         TGCACCTCATAGAGCGATTG        R
  *Pcdhb5*     3Pcdh_ß5_F       TGTGCTCACGCTCTACCTTG        F
  *Pcdhb5*     3Pcdh_ß5_R       CTCACTCCCACGAACATCAG        R
  *Pcdhb6*     PcdhB6-F         GTCAAGGACAATGGAGAACCTC      F
  *Pcdhb6*     PcdhB6-R         CTTCATCCTGTGAAGAGTCGTG      R
  *Pcdhb7*     pcdhb7_F         GACCTCATGGAGAAGCTGGA        F
  *Pcdhb7*     2-pcdhb7_R       GAGTTGTTGGCTCACTGCAA        R
  *Pcdhb8*     2-pcdhb8_F       ATTCCATGCCAGAAGAAACG        F
  *Pcdhb8*     2-pcdhb8_R       TAGTGGTCAGTTCCCCAACC        R
  *Pcdhb9*     2-pcdhb9_F       AACAAAGGAAGCAGACAAGAGC      F
  *Pcdhb9*     2-pcdhb9_R       TCACCGTGTTGCTCATAATCTC      R
  *Pcdhb10*    2PcdhB10-F       GGTATTTGAGCGTGATCTAGGG      F
  *Pcdhb10*    2PcdhB10-R       AGAGGGCGCTTCTTCTTCTAGT      R
  *Pcdhb11*    3Pcdh_beta11_F   CGACCACTCTCCAGAGTTCC        F
  *Pcdhb11*    3Pcdh_beta11_R   GCTGCCTTCAGAGGAAACAC        R
  *Pcdhb12*    pcdhb12_F        CTGGGATATATGGCAATGTCG       F
  *Pcdhb12*    pcdhb12_R        GTCAGACGGATTTCTCCTGTG       R
  *Pcdhb13*    2PcdhB13-F       GATAACGCTCCAGAAGTGATCC      F
  *Pcdhb13*    2PcdhB13-R       CTGCTGGTTATTTCCAGAGTCC      R
  *Pcdhb14*    2-pcdhb14_F      CCCAGCACACCATAACAGTG        F
  *Pcdhb14*    2-pcdhb14_R      GATGGTGCCTATGTGCAATG        R
  *Pcdhb15*    PcdhB15-F        CTCAGTCCGCTTACTGGAGAAT      F
  *Pcdhb15*    PcdhB15-R        AATGGTCTTTCCAACAGCAACT      R
  *Pcdhb16*    pcdhb16-F        TCATCCGTGAGAACAACAGC        F
  *Pcdhb16*    pcdhb16-R        GCAGCAGCGAGTAAGTGATG        R
  *Pcdhb17*    PcdhB17-F        AAGAGAGCACTTGACAGGGAAG      F
  *Pcdhb17*    PcdhB17-R        AGACCTGCACTGTTATGGTGTG      R
  *Pcdhb18*    PcdhB18-F        TGCATGGAGTCATACTTTGGAC      F
  *Pcdhb18*    pcdhb18-R        TAGCCATGTTTAGAAAGCAGCA      R
  *Pcdhb19*    3Pcdh_beta19_F   TTCGCTCTTCCTCCTCTCTG        F
  *Pcdhb19*    3Pcdh_beta19_R   AGTTCCCGCACTGTTAATGC        R
  *Pcdhb20*    PcdhB20-F        GAAGTGATCATGTCGTCGGTTA      F
  *Pcdhb20*    PcdhB20-R        CTTCCGTTGTCTCCAGAGTCTT      R
  *Pcdhb21*    2Pcdh_beta21_F   ACAGCACTCGGGCTTTCTAC        F
  *Pcdhb21*    2Pcdh_beta21_R   GGCAGCTCAGAGAGTGGTTC        R
  *Pcdhb22*    2Pcdh_beta22_F   GCTCTGCTAGCGTCACACTG        F
  *Pcdhb22*    2Pcdh_beta22_R   ATCACCTTCCTGGTGACTGG        R
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

As acknowledged by the three reviewers, your study highlights a novel and exciting role for this family of protocadherins in the death of cortical interneurons, by combining global genetic models and in vivo transplants. The revised version of the manuscript addresses most of the comments raised by reviewers. It provides a novel perspective on how the density of cortical interneurons is regulated together with activity-dependent processes.

**Decision letter after peer review:**

Thank you for submitting your article \"Clustered γ-Protocadherins Regulate Cortical Interneuron Programmed Cell Death\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Gordon Fishell (Reviewer \#1); Debra L Silver (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. In recognition of the fact that revisions may take longer than the two months we typically allow, until the research enterprise restarts in full, we will give authors as much time as they need to submit revised manuscripts.

This elegant study provides novel insights onto the mechanisms regulating the death of interneurons, which contributes to the proper functioning of cortical circuits and potentially to the etiology of neurodevelopmental disorders. The use of multiple experimental approaches reveals the roles of *Pcdh-*γ in regulating the survival of interneurons during the endogenous period of programmed cell death.

While all reviewers highlighted the quality and interest of the work, they also raised a numbers of concerns that you should be able to address without additional experimental manipulations.

Reviewer \#1:

This is a very nicely done paper by the group that first identified the rather large extent of cell death that occurs in interneuron populations derived from the MGE. I on the whole think it is a very solid paper well suited to publication in Life. I however have a number of queries I would like to see addressed.

The major thing I am confused about is the autonomous/non-autonomous actions of Cy3,4,5 protocadherins. While the authors do a nice job of ruling out an action of the α and β subforms and reverse the affect on cell death by crossing into the BAX background, I can\'t see how they imagine how the non-autonomous effects of mutant cells could have when transplanted with wild type cells they are co-injected with. In short they claim 92% autonomous effect and a 62% non-autonomous effect but how is that possible. Surely right after transplant the wild type cells interact with the host wild type cells not the mutant ones and given their argument that the migration and settling are unaffected by the loss of these isoforms, it is hard to imagine why they see such a pronounced non-autonomous effect. At very least they need to provide a plausible explanation.

They do a nice job up front showing that the CY3-5 isoforms are the ones most expressed during cell death but it is clear that the CY5 form is the one highest expressed. It would be nice to look at whether the expression of CY5 or all forms is affected in wild type cells when transplanted with the mutant cells with qPCR

Multiple papers (Burrone and Marin as referenced and Priya et al., which is not) all point to activity playing a role in cell death in interneurons. The authors look at the intrinsic properties in the mutant cells that survive and find no alterations, but the data clearly supports a like between activity and cell death. Ideally they would explore whether altering activity in interneurons with DREADDS or Kir2.1 affects protocadherin expression but at very least they should comment on the possible connection.

Reviewer \#2:

General Assessment of the Work: Overall, this paper presents evidence for *Pcdh-*γ as required for cIN survival during the endogenous period of PCD. The authors use a number of genetic mouse models to show that knocking out *Pcdh-*γ conditionally in cINs leads to a 50% reduction in surviving cINs at p30 without influencing proliferation and migration at embryonic stages. Additionally, they show that these findings are specific to *Pcdh-*γ and do not overlap with Pcdh-a or Pcdh-B. While it does promote cell death, knockdown of *Pcdh-*γ does not impair cIN morphology or physiological properties. Overall this work is interesting, technically elegant, and well performed. I have a few suggestions to better support their findings.

Major Concerns:

1\) In Figure 5C the authors use Bax^-/-^; Pcdh^-/-^ mice to show these contain far more cINs than their WT counterparts. However, this experiment is missing the Bax^-/-^ alone control. It is insufficient to just refer to a prior paper as these experiments may have been performed by a different investigator, who has a different quantification baseline, etc.

2\) The finding that survival of WT cINs is reduced in the presence of *Pcdh-*γ mutant cells is interesting. However, the evidence for this non-cell autonomous effect could be better strengthened. First they should include statistical comparisons comparing the reported fold changes in the presence and absence of the mutant cells (ie. Comparing data in Figures E and C). This observation would be strengthened with an experiment examining the survival of WT cINs transplanted into WT brains vs *Pcdh-*γ cKO brains.

3\) I found the results of some co-transplantation experiments with WT cells confusing. In Figure 8B co-transplantation of two fluorescent WT cells, the authors show that there is no reduction of cINs from 3DAT to 21DAT. However, based upon this work and that of Southwell et al., I would have expected some death by this stage of WT alone (since the intrinsic age of these cells would coincide with peak of programmed cell death). In Figure 8B\' with co-transplantation of WT and mutant cells, why is the survival fraction of WT cells now increasing from 6DAT to 13DAT and 21DAT? Similarly, in Figure 11B co-transplantation experiments, the survival fraction of WT cells is constant, but in Figure 11C it is increasing. These contradictory findings need to be addressed as they introduce concern about the validity of some of these transplantation experiments. The authors should also consider representing data not as survival fraction (which is not even defined in the Materials and methods) but instead as number of cells in the cortex (as they do in Figure 10C, E).

Reviewer \#3:

In \"Clustered γ-Protocadherins regulate cortical interneuron programmed cell death\", Mancia et al. provide clear and solid evidence about the function of γ-Protocadherins and more specifically that of γC3- γC4- γC5 isoforms in cortical interneuron (cIN) programmed cell death (PCD). The findings are in agreement with what it has been previously reported in other systems (spinal cord, retina) and although the authors provide no mechanism about the role of Pcdh-γ cluster in cIN PCD, the results are very interesting and they substantially enhance our knowledge on how the final number of cIN might be adjusted.

There are a couple of issues the authors should further elaborate/explain:

1\) One of the most interesting results of the paper came up from their cell transplantation experiments. The authors have used this technique (as it has been done in the past from the same group; Southwell et al., 2012) to investigate the survival of WT and different types of Pcdh- mutant cells in the same conditions (environment). In one of these experiments they show that by grafting MGE INs that comprise 50% Pcdh-γ mutant cells, the survival of the WT cells is decreased by approximately 20% compare to grafts consisted of 100% WT cells. This is suggestive of a non-cell autonomous mechanism of Pcdh-γ on cIN PCD. Taking into consideration that the Nkx2.1CRE line, used in this paper, labels only a percentage of the MGE cINs according to the original publication (Figure 6 in Xu et al., 2008), and others as well, it would be interesting to see what is happening within this mixed MGE population in control and mutant Nkx2.1CRE;Pcdh-γ mice. Do PV and SST escapers (ai14-negative; CRE-negative) survive less? This is particularly interesting since a recent paper in BioRxiv (Carriere et al., 2020) shows the opposite results (increased number of WT MGE cINs in the Pcdh-γ mutants). If this is the case and this result is verified, how do the authors explain the difference between heterochronic cell-transplantations and the homochronic cIN survival analysis?

2\) Concerning the same experiment, in the Discussion, they speculate that the increase in the WT cIN cell-death in the above transplantations, is related to the fact that WT cells fail to interact with other cINs of the same age and initiate an intracellular Pcdh-γ pro-survival signalling cascade. Therefore, is it a matter of percentages? What is expected if they try transplantations consisting of 10%, 25% or 75% mutant cells? And anyway, how do we know that is due to a failure of cell-cell interaction and not due to a neurotoxic effect of a big number of neurons dying, in which young INs of the same age are more vulnerable? We believe that the above experiments will further clarify their results and they are essential since there is no proposed mechanism.

3\) The Discussion is quite confusing. The authors suggest at least 3 potential mechanisms: 1) Population-cell autonomous mechanism. This model is based on cell-cell interactions between cINs, which is important for having the number of INs \"computed\" before arriving in the cortex (?). This is not explained very well. 2) A role, specifically for Pcdh-γC4, as it has been recently suggested that this is the isoform that mediates cell death (Garrett et al., 2019). Interestingly, this isoform might not be found on the cell-membrane, therefore it might not be implicated in cell-cell interactions (Garrett et al., 2019). 3) Finally, pyramidal neurons and interneurons may interact via the Pcdh-γ cluster (two possibilities presented), therefore a non-population autonomous mechanism. The authors should present all these possibilities but in a clear more constructive manner. In addition, they do not discuss at all, any potential pro-survival mechanisms that have been shown and might apply in cIN PCD as well. For example, in a recent paper (Duan et al., 2020) GABA signalling is suggested to be important for the survival of MGE derived INs (mentioned in the Discussion). Pcdh-γ-C5 isoform it has been shown to interact with GABAA receptors, stabilizing GABAergic synapses (Li et al., 2012). Can the authors comment on this?

10.7554/eLife.55374.sa2

Author response

> Reviewer \#1:
>
> This is a very nicely done paper by the group that first identified the rather large extent of cell death that occurs in interneuron populations derived from the MGE. I on the whole think it is a very solid paper well suited to publication in Life. I however have a number of queries I would like to see addressed.
>
> The major thing I am confused about is the autonomous/non-autonomous actions of Cy3,4,5 protocadherins. While the authors do a nice job of ruling out an action of the α and β subforms and reverse the affect on cell death by crossing into the BAX background, I can\'t see how they imagine how the non-autonomous effects of mutant cells could have when transplanted with wild type cells they are co-injected with. In short they claim 92% autonomous effect and a 62% non-autonomous effect but how is that possible. Surely right after transplant the wild type cells interact with the host wild type cells not the mutant ones and given their argument that the migration and settling are unaffected by the loss of these isoforms, it is hard to imagine why they see such a pronounced non-autonomous effect. At very least they need to provide a plausible explanation.

Since the concept of cell-autonomy was confusing and we present evidence for both cell autonomous and non-cell autonomous mechanisms, we have eliminated this wording from the text and instead now describe directly our observations:

In the Results section:

"Given these observations, we next asked how the presence of γ-Pcdh mutant cIN affected the survival of WT cIN in the transplantation setting. We co-transplanted 50K Gad67-GFP γ-Pcdh WT (GFP+) with 50K Nkx2.1::Cre;Ai14 γ-Pcdh mutant (tdTomato+) MGE cIN precursors and compared the survival of each population at 6 and 21 DAT. At 6 DAT the total number of tdTomato+ cells in the cortex of recipient mice was similar to that of GFP+ cells (Figure 10A, D and E). However, between 6 and 21DAT, the total number of GFP+ cells had decreased by an average of \~63% (Figure 10E, compared to Figure 10C). Compared to the \~40% of endogenous or transplanted WT cINs that are normally eliminated (present study and previous work (Southwell et al., 2012; Wong et al., 2018)), this experiment suggests that WT cells die at a higher rate (63%) when co-transplanted with γ-Pcdh mutant MGE cells. However, this observation would require additional animals for statistical confirmation. Regardless, the number of γ-Pcdh mutant (tdTomato+ cells) cINs decreased dramatically, by \~96% (Figure 10E). This experiment confirms that MGE cells lacking γ-Pcdh function are eliminated in far greater numbers than control MGE cells and show that the presence of γ-Pcdh WT cINs within a mixed population also affects the survival of mutant cINs (compare Figure 8 and Figure 10). These observations are consistent with the hypothesis that cINs interact with others of the same age discussed below.*"*

Our interpretation in the Discussion:

"Interestingly, the survival of WT cIN may also be reduced when co-transplanted with γ-Pcdh deficient MGE-cells although this difference did not reach statistical significance with the numbers of cases studied. If true, these findings would be consistent with the notion that cell-cell interactions among young cIN after their migration, is an essential step in determining their final numbers. However, we cannot exclude that the increase in the elimination of WT cells may result from a non-specific (e.g., toxic) effect of the increased cell death among γ-Pcdh mutant cells. If the latter occurs, the process is specific to the population of Nkx2.1^+^ MGE-derived cINs because there was no effect on cell death of WT CGE-derived VIP cINs (Figure 3E, Figure 3---figure supplement 1) or on non-Nkx2.1-derived SST or PV cells (Figure 3---figure supplement 4). Interactions mediated by γ-Pcdhs, and specifically among the C-isoforms, may directly or indirectly regulate survival of cINs of the same age and origin"

> They do a nice job up front showing that the CY3-5 isoforms are the ones most expressed during cell death but it is clear that the CY5 form is the one highest expressed. It would be nice to look at whether the expression of CY5 or all forms is affected in wild type cells when transplanted with the mutant cells with qPCR

This is an interesting experiment that could begin addressing the mechanism by which γ-Pcdhs regulate cIN survival. However, this is not a simple experiment; γ-Pcdhs, including isoforms γC3, γC4, and γC5 are expressed at low levels and their detection specifically in the subpopulation of WT or Mutant cells in our co-transplants, would require developing new methods to cleanly isolate WT cells. This will take at least a year and seems beyond the scope of the current MS: identifying the role that specific PCDHs play in cIN survival.

> Multiple papers (Burrone and Marin as referenced and Priya et al., which is not) all point to activity playing a role in cell death in interneurons.

We apologize for this oversight; we now include the reference to Priya et al.

> The authors look at the intrinsic properties in the mutant cells that survive and find no alterations, but the data clearly supports a like between activity and cell death. Ideally they would explore whether altering activity in interneurons with DREADDS or Kir2.1 affects protocadherin expression but at very least they should comment on the possible connection.

We do not know of any evidence of clustered Pcdhs being regulated by neuronal activity. This is an interesting suggestion for a follow-up study. Since clustered Pcdhs are expressed at very low levels this would require stringent controls to determine the expression per cell. This seems to be well beyond the scope of our study which focuses on the identification of γ-Pcdhs as key in the regulation of cell death.

> Reviewer \#2:
>
> General Assessment of the Work: Overall, this paper presents evidence for Pcdh-y as required for cIN survival during the endogenous period of PCD. The authors use a number of genetic mouse models to show that knocking out Pcdh-y conditionally in cINs leads to a 50% reduction in surviving cINs at p30 without influencing proliferation and migration at embryonic stages. Additionally, they show that these findings are specific to Pcdh-y and do not overlap with Pcdh-a or Pcdh-B. While it does promote cell death, knockdown of Pcdh-y does not impair cIN morphology or physiological properties. Overall this work is interesting, technically elegant, and well performed. I have a few suggestions to better support their findings.
>
> Major Concerns:
>
> 1\) In Figure 5C the authors use Bax^-/-^; Pcdh^-/-^ mice to show these contain far more cINs than their WT counterparts. However, this experiment is missing the Bax^-/-^ alone control. It is insufficient to just refer to a prior paper as these experiments may have been performed by a different investigator, who has a different quantification baseline, etc.

We had not included this control as the rescue previously reported for Bax^-/-^ mice [(Southwell et al., 2012)](https://paperpile.com/c/M85fLG/zKl8)) was very similar to that observed in the Bax^-/-^; γ-Pcdh^fcon3/fcon3^ mice. However, to have this analysis done by the same person, we now include control animals that were Bax^-/-^ but γ-Pcdh^fcon3/+^ (heterozygous for γ-Pcdh). This data has been added to Figure 5C. The number of cIN in Bax^-/-^ ;γ-Pcdh^fcon3/+^ mice was very similar to that observed in Bax^-/-^ ;γ-Pcdh^fcon3/fcon3^ mice.

In the Results section:

"Importantly, the homozygous deletion of the pro-apoptotic BCl^-^2-associated X protein (BAX) rescued cIN density in the γ-Pcdh mutant mice to levels similar to those observed in control BAX^-/-^ ;Pcdh^fcon3/+^ mice or in mice carrying only the BAX mutation (BAX^-/-^) (Southwell et al., 2012) (Figure 5C )"

> 2\) The finding that survival of WT cINs is reduced in the presence of Pcdh-y mutant cells is interesting. However, the evidence for this non-cell autonomous effect could be better strengthened. First they should include statistical comparisons comparing the reported fold changes in the presence and absence of the mutant cells (ie. Comparing data in Figures E and C). This observation would be strengthened with an experiment examining the survival of WT cINs transplanted into WT brains vs Pcdh-y cKO brains.

We have compared the fold change in the number of cINs between 6 and 21 DAT when transplanting WT-WT or WT-γ-Pcdh^fcon3/fcon3^ cINs. In the case of WT-WT transplants we observed a 39% drop in cIN number. For the WT-γ-Pcdh^fcon3/fcon3^ transplant we observed that WT dropped 63% and the γ-Pcdh^fcon3/fcon3^ cells dropped by 96%. This suggests that cell death among WT cINsis increased when mutant cells are present. Clearly 63% death is very different to the elimination of \~40% for endogenous WT cells (Southwell et al., 2012) or for transplanted WT cells in the present study. However, statistical analysis would require larger n (Mann Whitney test with current data comparing the relative change from 6 to 21 DAT in the WT population from WT-WT co-transplants to the relative change from 6 to 21 DAT in the WT population from WT-γ-Pcdh^fcon3/fcon3^ co-transplants shows a p value of 0.0519. We explain in the MS. that this is a suggestion and further experiments would be required to clearly determine how WT cIN cell death is affected by the presence of the γ-Pcdh^fcon3/fcon3^ cINs. The suggested experiment of transplanting WT cells into γ-Pcdh mutant environment is an interesting one, but not easy to interpret. We assume the reviewer was referring to transplantation into the Nkx2.1::Cre;γ-Pcdh^fcon3/fcon3^ mice as the straight γ-Pcdh^fcon3/fcon3^ mice die at birth. However, in this heterochronic transplantation, unlike our co-transplantation experiment, the transplanted E13.5 WT cINs would be a few days younger than the host mutant cINs (P2-6) and therefore at a different stage of their maturation. It would be interesting to transplant homochronically E13.5 WT cells into E13.5 Nkx2.1::Cre;γ-Pcdh^fcon3/fcon3^ embryos, but this experiment would require several months as it requires transplantations into the embryos.

> 3\) I found the results of some co-transplantation experiments with WT cells confusing. In Figure 8B co-transplantation of two fluorescent WT cells, the authors show that there is no reduction of cINs from 3DAT to 21DAT. However, based upon this work and that of Southwell et al., I would have expected some death by this stage of WT alone (since the intrinsic age of these cells would coincide with peak of programmed cell death). In Figure 8B\' with co-transplantation of WT and mutant cells, why is the survival fraction of WT cells now increasing from 6DAT to 13DAT and 21DAT? Similarly, in Figure 11B co-transplantation experiments, the survival fraction of WT cells is constant, but in Figure 11C it is increasing.

We apologize for this confusion; Indeed the number of both WT and γ-Pcdh^fcon3/fcon3^ mutant cells decreases in these co-transplantations. Our plots represent the fraction, from all transplant-derived cells (WT+ γ-Pcdh^fcon3/fcon3^ mutant cINs), that are WT or mutant at the different times after transplantation. Although the total number of both WT and γ-Pcdh^fcon3/fcon3^ mutant cells decreases, with increasing survival after transplantation, the fraction of cells that are WT becomes progressively higher compared to the fraction of mutant cells. In the co-transplantation of WT-WT, both populations decrease at equal rates and therefore at the different times they maintain similar proportions. This has now been clarified in the text (Results and Materials and methods sections) and in the first figure legend where this type of plots are presented. We have also added a supplementary figure to Figure 8 (Figure 8---figure supplement 1) where the absolute numbers of WT and γ-Pcdh^fcon3/fcon3^ mutant cells are plotted. The calculation to determine survival fraction is defined in Materials and methods. In supplementary Figure 1 to Figure 10 we also present the absolute numbers for cIN cell death in the co-transplantation of: WT-WT and WT-mutant cells.

In the Results section:

"While equivalent numbers of red and green cells were mixed before being transplanted, the absolute number of cells transplanted varied from transplant to transplant. In order to compare the survival, we use the fraction of green or red cells, among all co-transplanted cells (red+green). The fraction of surviving GFP+ and tdTomato+ cells at 3, 6, 13 and 21 days after transplantation (DAT) was measured (Figure 8A and B, top graph). "

" However, the fraction of γ-Pcdh mutant cINs (tdTomato+) surviving was dramatically lower when the transplanted cells reached a cellular age equivalent to that of endogenous cIN after the normal wave of programmed cell death (6DAT is roughly equivalent to P0; 21DAT is roughly equivalent to P15) (Southwell et al., 2012). Note that in this experiment the proportion of WT cells increases during this same period. This change in proportion is not a reflection of increased survival, as these cells also undergo elimination by programmed cell death (see below)(Figure 8---figure supplement 1), but that, with the increased loss of mutant cells, the WT cells account for a larger fraction of the total."

In the material and methods section:

"In some experiments the absolute number of grafted cells varies between transplants; hence we report findings as the fraction of cells (GFP+ or tdTomato+) that survive from the total transplant-derived cell number in that animal (GFP + tdTomato-positive) (Figure 8). We determined for these experiments the number of transplant-derived cells of the different genotypes before and, in different animals, after the period of cell death. For some experiments we also quantified the number of transplant-derived cells during the period of cell death (Figure 12B). In data presented as the fraction of transplant-derived cells (Figure 8 and Figure 11), GFP positive and tdTomato-positive cells were counted from coronal sections along the rostral-caudal axis in at least 10 sections per animal. The number of GFP or tdTomato-positive cells was divided by the total cell number (GFP + tdTomato) in that section. This fraction does not reflect the absolute number of cells, but their relative contribution to the overall population of transplant-derived cells at different DAT. For one experiment (Figure 10), we calculated the absolute number of transplant-derived WT (GFP) and γ-Pcdh^fcon3/fcon3^ (tdTomato) cells. For this experiment, 50K cells of each genotype were counted before transplantation."

> These contradictory findings need to be addressed as they introduce concern about the validity of some of these transplantation experiments. The authors should also consider representing data not as survival fraction (which is not even defined in the Materials and methods) but instead as number of cells in the cortex (as they do in Figure 10C, E).

This has been clarified above. Note that in Figure 10, we present absolute numbers of transplant derived cINs. For this more stringent experiment we counted the number of cells transplanted and made sure that equal numbers of mutant and WT cells were transplanted. This has now been clarified as indicated above in the Materials and methods and Results' sections.

> Reviewer \#3:
>
> In \"Clustered γ-Protocadherins regulate cortical interneuron programmed cell death\", Mancia et al. provide clear and solid evidence about the function of γ-Protocadherins and more specifically that of γC3- γC4- γC5 isoforms in cortical interneuron (cIN) programmed cell death (PCD). The findings are in agreement with what it has been previously reported in other systems (spinal cord, retina) and although the authors provide no mechanism about the role of Pcdh-γ cluster in cIN PCD, the results are very interesting and they substantially enhance our knowledge on how the final number of cIN might be adjusted.
>
> There are a couple of issues the authors should further elaborate/explain:
>
> 1\) One of the most interesting results of the paper came up from their cell transplantation experiments. The authors have used this technique (as it has been done in the past from the same group; Southwell et al., 2012) to investigate the survival of WT and different types of Pcdh- mutant cells in the same conditions (environment). In one of these experiments they show that by grafting MGE INs that comprise 50% Pcdh-γ mutant cells, the survival of the WT cells is decreased by approximately 20% compare to grafts consisted of 100% WT cells. This is suggestive of a non-cell autonomous mechanism of Pcdh-γ on cIN PCD. Taking into consideration that the Nkx2.1CRE line, used in this paper, labels only a percentage of the MGE cINs according to the original publication (Figure 6 in Xu et al., 2008), and others as well, it would be interesting to see what is happening within this mixed MGE population in control and mutant Nkx2.1CRE;Pcdh-γ mice. Do PV and SST escapers (ai14-negative; CRE-negative) survive less? This is particularly interesting since a recent paper in BioRxiv (Carriere et al., 2020) shows the opposite results (increased number of WT MGE cINs in the Pcdh-γ mutants). If this is the case and this result is verified, how do the authors explain the difference between heterochronic cell-transplantations and the homochronic cIN survival analysis?

We have now performed the quantification of the un-recombined PV and SST cells and consistent with (Carriere et al., 2020) we see a significant increase in the density of PV+/Ai14- and SST+/Ai14- cells in Nkx2.1::Cre;Ai14;γ-Pcdh^fcon3/fcon3^ mice. Most likely these un-recombined cells are derived from the most dorsal MGE at the interface with LGE (Hu, et al., 2017; Fogarty et al., 2007; Sousa et al., 2009). This region does not express, or expresses very low levels, of NKX2.1, but expresses NKX6.2 (Sousa et al., 2009; Fogarty et al., 2007) and generates a subpopulation of SST and PV cINs. We do not know if the presence of the conditional γ-Pcdh^fcon3^ allele results in increased production of these cells or if un-recombined cells from this domain increase their survival to compensate for the loss of Nkx2.1-cIN lacking γ-Pcdh function. If the latter is true it is indeed interesting that the behavior of these cells differs from that observed for WT cells co-transplanted with MGE cells lacking γ-PCDH function. Understanding these differences will require additional experiments to determine if cell-birth, migration or survival is affected among un-recombined PV and SST cINs. Since in our transplants we can only see the recombined cells, an additional reporter for all MGE cells (Nkx2.1 and Nkx6.2) will be required to study the phenomenon using transplantation. We have added a description of these findings in the Results section and a brief comment in the Discussion.

In Results:

"Interestingly, we observed that in our *Nkx2.1::Cre;Ai14; γ-Pcdh^fcon3/fcon3^* mice, the number of un-recombined PV and SST (PV+/Ai14- and SST+/Ai14-) cells was significantly increased compared to WT mice (Figure 3---figure supplement 4), a result consistent with recent observations (Carriere et al., 2020). PV+/Ai14- and SST+/Ai14- cells are likely derived from the most dorsal MGE at the interface with LGE expressing Nkx6.2 in a region of low, or no expression of Nkx2.1 (Hu et al., 2017; Fogarty et al., 2007; Sousa et al., 2009; Hu et al., 2017). We do not know if the presence of the conditional FCON3 allele results in increased production of these cells or if un-recombined cells from this domain increase their survival in compensation for the loss of cIN that lack Pcdh-γ function. If the latter is true, the behavior of these un-recombined PV and SST cINs differs from that observed for WT cells co-transplanted with MGE cells lacking Pcdh-γ function (see below)."

In the Discussion:

"Consistent with recent observations (Carriere et al., 2020), the number of un-recombined PV and SST (PV+/tdTomato- and SST+/tdTomato-) cINs in *Nkx2.1::Cre;Ai14; γ-Pcdh^fcon3/fcon3^* mice, increased compared to WT mice (Figure 3---figure supplement 4). These cells, which are likely derived from the dorsal Nkx6.2+/Nkx2.1- MGE domain (Hu et al., 2017; Fogarty et al., 2007; Sousa et al., 2009; Hu et al., 2017) may increase their survival in compensation for the loss of Nkx2.1-derived cINs lacking Pcdh-γ function. However, we cannot exclude that the increased number of un-recombined PV and SST cells in *Nkx2.1::Cre;Ai14; γ-Pcdh^fcon3/fcon3^* mice resulted from increased production or migration of cIN derived from regions of low, or no, expression of Nkx2.1. Further experiments will be required to understand the origin of these un-recombined PV+/Ai14- and SST+/Ai14- cINs and whether the observed increase in their numbers is due to compensatory survival mechanisms."

> 2\) Concerning the same experiment, in the Discussion, they speculate that the increase in the WT cIN cell-death in the above transplantations, is related to the fact that WT cells fail to interact with other cINs of the same age and initiate an intracellular Pcdh-γ pro-survival signalling cascade. Therefore, is it a matter of percentages? What is expected if they try transplantations consisting of 10%, 25% or 75% mutant cells? And anyway, how do we know that is due to a failure of cell-cell interaction and not due to a neurotoxic effect of a big number of neurons dying, in which young INs of the same age are more vulnerable? We believe that the above experiments will further clarify their results and they are essential since there is no proposed mechanism.

This is correct; we cannot distinguish between decreased interactions or increased toxicity as a by-product of increased dying cells among the mutant cells. We now make it clear that the decreased interaction, as a result of the presence of mutant cells, is a hypothesis and that other interpretations (e.g. toxic effect from the dying mutant cells) are possible. We have performed experiments transplanting different proportions of mutant and WT cells (see graphs in [Author response image 1](#respfig1){ref-type="fig"}), as suggested by this reviewer, and see that the number of dying WT cells in a co-trasnplant in which the majority (80%) of cells are mutant (80 Mutant: 20 WT) appears (by the slope of the change between 3 and 21 DAT) to be similar to that when transplant is 50:50. However, this experiment is preliminary and many more transplants would be required to make an accurate comparison. While the experiment is interesting and would suggest that the presence of mutant cells in any number equally conditions the survival of WT cells, this experiment does not allow us to distinguish between the toxic or interaction hypotheses.
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> 3\) The Discussion is quite confusing. The authors suggest at least 3 potential mechanisms: 1) Population-cell autonomous mechanism. This model is based on cell-cell interactions between cINs, which is important for having the number of INs \"computed\" before arriving in the cortex (?). This is not explained very well. 2) A role, specifically for Pcdh-γC4, as it has been recently suggested that this is the isoform that mediates cell death (Garrett et al., 2019). Interestingly, this isoform might not be found on the cell-membrane, therefore it might not be implicated in cell-cell interactions (Garrett et al., 2019). 3)

The Discussion has been clarified and the speculation that cIN numbers may be "computed" before cINs arrive in the cortex has been eliminated. It is indeed interesting that γ-Pcdh C4 may be key to the regulation of interneuron survival, not only the spinal cord [(Garrett et al., 2019)](https://paperpile.com/c/M85fLG/lphQU) but also in other parts of the CNS (this is briefly discussed). These mice were made available to us through the laboratory of Joshua Weiner before the lock-dawn, but this transfer is now delayed. Our understanding is that γC4 is in the membrane, but unlike other PCDHs it requires binding to b PCDHs in the Α or Gama gene clusters to be transported to the membrane [(Thu et al., 2014)](https://paperpile.com/c/M85fLG/9Astd).

In the Discussion:

"A recent study suggests that the 𝛾C4 isoform is the key mediator in the regulation of neuronal cell death in the spinal cord [(Garrett et al., 2019)](https://paperpile.com/c/M85fLG/lphQU). How the specific 𝛾C4 isoform in the γ-Pcdh cluster mediates cell death remains a fundamental question for future research. Interestingly, the 𝛾C4 isoform appears to be unique in that it is the only Pcdh isoform that does not bind in a homophilic manner [(Garrett et al., 2019)](https://paperpile.com/c/M85fLG/lphQU) and it is not translocated to the membrane unless it is associated with other α- or γ-Pcdhs [(Thu et al., 2014)](https://paperpile.com/c/M85fLG/9Astd). The mechanism by which the 𝛾C4 isoform regulates cell-cell interactions among young cINs, leading to the adjustment of local circuit neuron numbers, remains unclear."

> Finally, pyramidal neurons and interneurons may interact via the Pcdh-γ cluster (two possibilities presented), therefore a non-population autonomous mechanism. The authors should present all these possibilities but in a clear more constructive manner. In addition, they do not discuss at all, any potential pro-survival mechanisms that have been shown and might apply in cIN PCD as well. For example, in a recent paper (Duan et al., 2020) GABA signalling is suggested to be important for the survival of MGE derived INs (mentioned in the Discussion). Pcdh-γ-C5 isoform it has been shown to interact with GABAA receptors, stabilizing GABAergic synapses (Li et al., 2012). Can the authors comment on this?

Thank you for this suggestion. We have re-organized the Discussion as follows.

In the Discussion:

"The co-transplantation assay, implemented in the present study, provides strong evidence that γ-Pcdhs in cIN are key to their selection by programmed cell death. γ-Pcdhs could be mediating initial cell-cell interactions that are important for the survival of cINs. Two non-exclusive possibilities exist: (1) γ-Pcdh mediate cell-cell interaction among young cIN to adjust their population size, and levels of inhibition, according to the numbers that reached the cortex; (2) γ-Pcdh mediate interactions with locally produced excitatory pyramidal neurons to adjust final numbers according to local levels of excitation. For the latter, MGE-derived cIN could interact with pyramidal neurons via γ-Pcdh C-isoforms. However, alternative \# 2 is unlikely to explain how γ-Pcdhs adjust cIN numbers; data using conditional removal of γ-Pcdh in pyramidal cells show no effect on the survival of cINs (Carriere et al., 2020). However, we cannot exclude that initial connectivity with excitatory pyramidal neurons may indeed require the proper expression of γ-Pcdh among cIN through non-homophilic interactions."

"A recent study has shown that coordinated activity of synaptically connected assemblies of cINs is essential for their survival [(Duan et al., 2020)](https://paperpile.com/c/M85fLG/DMqit). Pyramidal cells receive information from these assemblies via GABA~A~γ2-signaling and through the de-synchronization of their activity regulate cIN program cell death. γ-Pcdhs could be important in bringing together cINs of a common origin and at similar stages of maturations for the formation of initial cINs functional assemblies. The formation of these assemblies of synchronously firing cIN and the subsequent selection by pyramidal driven de-synchronization could explain both cell/population autonomous [(Southwell et al., 2012)](https://paperpile.com/c/M85fLG/zKl8)), and non-cell autonomous [(Wong et al., 2018)](https://paperpile.com/c/M85fLG/WfY1X) mechanism of cIN programmed cell death. Interestingly, the Pcdh isoform γC5 binds to the GABA~A~γ subunit of the GABA receptor [(Li et al., 2012)](https://paperpile.com/c/M85fLG/1dZA), but the role of γC5-GABA~A~γ interaction on neuronal survival remains unknown. The transplantation assay provides a powerful tool to further study how γ-Pcdhs, cell-cell interactions, and cellular age contribute to cIN selection. It will be interesting, for example, to determine if heterochronically transplanted cINs form functional assemblies and whether these assemblies are affected by the removal of different γ-Pcdhs."

[^1]: BrainEver, Paris, France.

[^2]: These authors contributed equally to this work.
